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Chronic obstructive pulmonary disease (COPD) is characterized by an abnormal 
inflammatory response to inhalation of noxious agents, particularly cigarette smoke (CS), which 
leads to a progressive and poorly reversible decline in lung function. Autophagy, a highly 
conserved adaptive response to cellular stresses, which removes cytoplasmic components such as 
organelles and long-lived proteins via encapsulation and lysosome-dependant degradation, has 
also been implicated in cell death pathways. We previously observed autophagy protein 
induction and autophagosome accumulation in in vivo and in vitro models of experimental 
COPD, as well as in COPD patients. The regulation and function of autophagy in CS-induced 
COPD have not been fully elucidated.   
To delineate the role of autophagy in the response of lung epithelial cells to CS we 
developed a novel in vitro model of mainstream CS exposure in primary mouse tracheal 
epithelial cells (MTECs) differentiated at an air-liquid interface (ALI). MTEC cultures in 
response to CS in vitro recapitulated many features of CS exposure in vivo, including 
autophagosome accumulation, cilia shortening, misfolded protein aggregation, loss of tight 
junction integrity and cell death. In vitro we discovered that sublethal doses of CS enhanced 
selective autophagic flux, while CS-induced cytotoxicity was associated with decreased 
autophagic activity and autophagosome accumulation. We also discovered that autophagic flux is 
induced in vivo upon acute exposure, but is not significantly upregulated following chronic 6 
month exposure to CS. Both LC3B-/- and Beclin-1+/- mice and MTEC cultures were protected 
from CS induced injury, indicating that these autophagy proteins promote epithelial cell death. 
Moreover, we investigated the effects of CS on autophagic substrates. HDAC6 regulates 
autophagosome-lysosome fusion, autophagic degradation of ubiquitinated protein aggregates, 
and cilia resorption. Cytotoxicity and protein aggregate accumulation were observed basally in 
HDAC6-/Y derived MTEC cultures, while CS-exposed mice were more vulnerable to 
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emphysematous changes.  Evidence of autophagic degradation of cilia components was also 
observed following CS treatment. These data indicate that autophagy plays a complex role in 
COPD pathogenesis, in which CS-induced autophagy both removes deleterious protein 
aggregates and contributes to apoptosis.  
 vi 
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1.0  INTRODUCTION 
Chronic obstructive pulmonary disease (COPD) is a leading cause of mortality and morbidity 
worldwide (1). The primary etiological agent of COPD is cigarette smoke (CS), which promotes 
the pathogenesis of chronic bronchitis and emphysema (2). At the molecular level development 
of COPD is primarily attributed to imbalances in oxidant, inflammatory and protease pathways 
(3). Recently implicated in COPD, autophagy is a lysosome-dependent degradative process 
promoting both cytoprotection via degradation of damaged organelles and proteins as well as cell 
death (4-8). Since there are relatively few treatment options available to COPD patients, 
elucidating the roles of autophagy in this disease may yield valuable insights for future therapies. 
1.1 COPD 
COPD affects 10% of the global population over 40 years of age with billions of dollars spent 
each year on treatment in the US alone. Extrapolations predict that COPD will be the third 
leading cause of death worldwide by 2020 (1). In developing countries exposure to 
environmental pollution, particularly biomass fuels, is an increasingly prevalent cause of disease 
pathogenesis. Since only 10-20% of smokers develop COPD, this is a strong indication that 
genetic factors play a critical role in disease vulnerability. Rigorous genomic studies are 
underway to identify disease susceptibility loci (9-11).  
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1.1.1  COPD pathology 
COPD pathology is complex with significant patient-to-patient variation, as the disease manifests 
degrees of emphysema, small airway remodeling, and chronic bronchitis (12-14). Patients with 
COPD experience an accelerated decline in forced expiratory volume in one second (FEV1), as 
well as, increased resistance in the conducting airways and reduced lung compliance (2, 9). 
Chronic bronchitis is characterized by inflammation of the airways with mucus gland 
hypertrophy and hyperplasia. The resultant mucus hypersecretion further obstructs airways 
already narrowed by inflammation and fibrosis. Emphysema is defined as permanent 
enlargement of airspaces due to loss of alveolar cells, which leads to significant reductions in gas 
exchange area and contributes to loss of lung elastic recoil, thereby restricting airflow. Difficulty 
breathing, dyspnea, commonly associated with COPD reduces capacity for physical activity and 
promotes co-morbidities such as muscle weakness and osteoporosis. Recent studies have begun 
to focus on the systemic effects of COPD, including the contribution of increased inflammatory 
mediators in the serum to the disease process (15-18). Patients with COPD frequently have co-
morbid cardiovascular disease including arterial stiffness, endothelial cell dysfunction, and a 
propensity for the formation of atherosclerotic plaques (19, 20). COPD is also correlated with 
increased risk of diabetes, suggesting that metabolic pathways are also affected in this disease 
(21, 22).  
1.1.2 COPD molecular mechanisms of disease 
Considerable insights into the molecular mechanisms of COPD have been gained through 
studying the imbalances in oxidative metabolism, inflammation and protease activity. These 
molecular pathways are interdependent, frequently acting in concert to promote disease 
pathogenesis.  
CS contains thousands of free radicals in each puff and imposes a significant oxidative 
stress for epithelial cells; therefore, both intracellular and extracellular antioxidant metabolism is 
critical. The key transcription factor mediating the antioxidant stress response is nuclear factor 
E2-related factor 2 (Nrf-2). Expression of this protein, which binds to antioxidant response 
elements, is increased by CS, but decreased in the disease state. Nrf-2 deficient mice are 
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susceptible to CS induced airspace enlargement, suggesting that this transcription factor is a 
critical determinant of disease susceptibility (23-25).  
Particulate and vapor phase constituents of CS activate chronic inflammatory pathways 
beginning with activation of macrophages and recruitment of neutrophils through the release of 
chemotactic factors, such as interleukin-8 (IL-8) and leukotriene B4 (LTB4) (26-28). Activation 
of cytotoxic T lymphocytes (CD8+), which target epithelial cells for destruction, has also been 
implicated in this inflammatory cascade. (29). Neutrophils release neutrophil elastase (NE) and 
the oxidative environment promotes the activity of macrophage-derived matrix 
metalloproteinases (MMPs), which degrade connective tissue components, such as elastin, 
collagen and fibronectin (30-32). Extracellular matrix loss then induces detachment associated 
epithelial cell death, anoikis.  
Excessive protease activity contributes to the development of autoimmunity by producing 
an abundance of extracellular matrix self-antigens in an inflammatory setting (33).  Protease 
activities in the lung are usually balanced by antiproteases, such as α-1 antitrypsin (A1AT), 
secretory leukoprotease inhibitor (SLPI), and tissue inhibitors of matrix metalloproteases 
(TIMPs) (34-37). Mutations in the A1AT gene were the first genetic factors implicated in the 
development of emphysema. There is complex interdependence among these three processes and 
variability between patients, which has impeded the development of effective therapeutics. 
1.1.3 In vivo models of COPD 
COPD, particularly emphysematous changes, have been studied in rodents, dogs, guinea pigs, 
monkeys, and sheep (38, 39). With the advent of modern genetic manipulations, mice have 
become the model of choice; however, there are noteworthy differences between mouse and 
human pulmonary anatomy (40). Mice have less extensive airway branching and do not normally 
have respiratory bronchioles. The majority of cells in the human bronchial tree are ciliated and 
there is an abundance of goblet cells, both of which decline in approaching the terminal 
bronchioles, while Clara-like cells dominate in the mouse respiratory tract and goblet cells are 
extremely rare. Only 37% of the murine airway cells are ciliated, which occur in heterogeneous 
patches.  Bronchial glands, which are hypertrophied and hyperplastic in chronic bronchitis, are 
only present in the mouse trachea (41-43).  
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There are a number of methods used to produce emphysematous changes in mouse 
models. Intratracheal instillation into the lungs of lipopolysaccharide (LPS), elastase, and 
vascular endothelial growth factor (VEGF) inhibitors all induce varying degrees of apoptosis and 
inflammation (44-48). However, CS exposure to mice is most similar to human COPD and 
causes physiological alterations resulting in emphysema and airway remodeling. The 
disadvantage of this model is that disease development takes at least 3-6 mo to develop and is 
milder, nonprogressive, and certain features, such as goblet cell metaplasia, will regress after 
smoking cessation. Also, due to a lack of bronchial glands, mice are a poor model of mucus 
hypersecretion.  
There are strain dependent variations in the development of CS-induced emphysema in 
mice, potentially providing insights into the mechanistic basis of this disease (49). The mouse 
strain AKR/J is most susceptible CS injury, showing 30% increase in airspace enlargement by 
mean linear intercept (Lm). AKR/J mice exposed to CS for 6 mo demonstrate a significant 
decrease in tissue elastance and increased compliance along with the production of 
proinflammatory cytokines and infiltration of neutrophils, macrophages, and Th1 associated 
lymphocytes. The C57BL/6 strain is less susceptible to emphysema with a 13% increase in Lm 
following 6 mo of exposure; however, lung mechanics remained unchanged in this strain. 
Finally, NZWlac/J mice are resistant to CS induced emphysema (49). Valuable insights have 
been gained from the mouse CS model due to the ease of genetic manipulation. 
1.1.4 In vitro models of COPD 
CS contains more than 4,000 chemicals and fundamental molecular mechanisms of this complex 
mixture have been elucidated from the development of in vitro cultures treated with specific 
toxic components such as paraformaldehyde, nicotine, and even general oxidative stressors such 
as H2O2 (50-57). In an effort to more fully mimic CS exposure, cells have also been treated with 
CS condensate (CSC) and CS extract (CSE), which involve solubilizing solid components that 
deposit following combustion and collecting hydrophobic constituents by bubbling smoke 
through media, respectively (58-60). These treatment strategies have been applied to numerous 
cell types including cell lines of epithelial, endothelial, mesenchymal, and hematopoietic 
lineages (16, 61-70). Recent studies have sought greater physiological relevance by growing 
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cells on transwells and treating the cells at an ALI with mainstream CS (71-73). From these 
studies careful dose and kinetic assays have been performed, evaluating the stress responses 
instigated to maintain cellular homeostasis, as well as, the identification of key players involved 
in mediating CS-induced cell death.    
1.1.5 Effects of CS on the respiratory epithelium 
In vivo and in vitro studies indicate that there are complex interactions between adaptive and 
pathological responses, which depend on the dose, time and duration of CS exposure (74-76).  
CS induces structural changes, activation of stress responses and cell death. Acute responses 
include regulated loss of epithelial barrier integrity via disruption of intercellular contacts (72, 
77). Microarray analysis of epithelial cells exposed to CS report acute downregulation of 
transcription (73). There is also increased antioxidant pathway activation and RNA processing 
(73). A number of studies have demonstrated upregulation of the unfolded protein response 
(UPR) and endoplasmic reticulum associated degradation (ERAD) pathways with CS exposure 
(78, 79). Activation of prosurvival and proinflammatory transcription factor, nuclear factor κ-
light-chain-enhancer of activated B cells (NFκB), has also been implicated, promoting the 
transcription of IL-6, IL-8 and other proinflammatory cytokines (80-85).  
Ciliated cells represent a large proportion of the apical surface area of the respiratory 
epithelium and are vulnerable to CS-induced injury (86-89). Cilia are microtubule-based 
organelles formed by specialized centrioles, called basal bodies, which dock at the plasma 
membrane and nucleate the axoneme. While the ciliary membrane is continuous with the plasma 
membrane, cilia are discrete organelles due to transition fibers at the base of each cilium that 
regulate protein import and export (90, 91). Motile ciliary axonemes are comprised of 9 outer 
doublet microtubules and a central pair, a 9+2 structure. Cilia are dynamic organelles dependent 
on intraflagellar transport (IFT). Continuous kinesin dependent anterograde trafficking adds cilia 
components to the distal tip of the cilium, while dynein-dependent retrograde trafficking recycles 
materials to the cell body (92, 93). Recently, ubiquitination of cilia components in the axoneme 
has been implicated in cilia resorption; however, lack of ciliary proteasomal activity suggests 
that tagged proteins are degraded in the cytoplasm (94). 
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Early studies demonstrated that CS can increase and decrease ciliary beat frequency 
through protein kinase C (PKC) and purinergic signaling, as well as evidence for both increased 
and decreased proportions of ciliated cells lining the airways (75, 76, 87, 89, 95). These data 
provide examples of the epithelium dynamically adapting to CS-induced stress. CS cytotoxicity 
also causes desquamation of the epithelium, which has been shown to induce squamous cell 
metaplasia through the dedifferentiation of neighboring viable cells, which then proliferate to 
regenerate an intact epithelium. Chronic CS exposure inhibits differentiation of ciliated cells and 
promotes repopulation with goblet cells producing a hyersecretory phenotype (Figure 1) (96, 
97).  
Recent studies in human populations have noted a significant change not only in ciliated 
cell number, but also, cilia length in the respiratory epithelium of healthy smokers. Modeling of 
these effects suggested a significant defect in mucociliary clearance even in healthy smokers 
(88).  Since mucociliary clearance is the primary innate defense mechanism of the lung, CS-
induced cilia injury leaves lungs vulnerable to disease-promoting infections.  
Figure 1. The effects of CS on mucociliary clearance in the respiratory epithelium. A) Mucociliary 
clearance is the primary innate defense mechanism of the lung. Goblet cells secrete mucins, which trap 
particulates and pathogens in the mucus layer. Ciliated cells push the mucus out of the lungs by coordinated 
beating of the cilia. B) Exposure to CS induces inflammation, oxidative stress, and protease activity. In this 
environment, epithelial cell apoptosis is increased and the remaining cells undergo dedifferentiation and 
squamous cell metaplasia to protect the underlying interstitium. Upon recovery of the intact epithelium, 
goblet cell differentiation dominates and cilia shorten leading to a disruption of mucociliary clearance, 
ultimately promoting airway obstruction.  
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1.1.6 COPD management and treatment 
There are limited therapeutic options for the management of COPD. Smoking cessation is the 
first step in all treatment strategies, which reduces the rate of decline in remaining lung function, 
but fails to reverse established disease. Pulmonary rehabilitation through structured programs of 
education and physiotherapy has been shown to improve exercise capacity and quality of life in 
patients. Bronchodilators, such as anticholinergics and β2 andrenoreceptor agonists promote a 
less than 10% increase in FEV1, as well as, reducing dyspnea and increasing exercise tolerance. 
Treatment with corticosteroids is controversial and seems most effective in patients with 
coexistant asthma. Generally, corticosteroids in combination with broad spectrum antibiotics are 
effective during acute exacerbations, but fail to prevent disease progression and are avoided for 
routine disease management.  As lung function declines, long-term oxygen therapy is indicated 
(98-105).  Lung transplantation remains a viable therapeutic option for some patients with end 
stage COPD. 
1.2 AUTOPHAGY 
The process of autophagy is named from the Greek “to eat oneself” and is a lysosome-dependent 
mechanism for the removal of cytoplasmic constituents (106-108).  There are three distinct 
autophagic pathways, microautophagy, chaperone-mediated autophagy and macroautophagy. 
Small invaginations that pinch-off into the lysosomal membrane characterize microautophagy 
(109, 110).  Chaperone-mediated autophagy requires chaperone proteins Hsc70, Hsp40, Hip and 
Hop interacting with lysosome–associated membrane protein (LAMP) 2 to specifically transport 
unfolded proteins containing the KFERQ targeting motif into the lysosomal lumen (111-113). 
The primary focus of these studies is macroautophagy, herein referred to as autophagy, which is 
responsible for the bulk degradation of cytoplasmic constituents including organelles, proteins 
and protein aggregates (114).  
Autophagy initiation requires the formation of a phagophore, which elongates and 
matures into the double-membraned autophagosome. Once formed, autophagosomes fuse with 
various components of the endocytic pathway, such as endosomes, forming hemiphagsomes. 
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Ultimately these structures fuse with the lysosome, and the internal membrane and constituents 
are degraded by lysosomal hydrolases in the autophagolysosome (Figure 2). Freed amino acids 
along with other building blocks, are recycled to the cytoplasm via specialized permease 
channels (106). Autophagy plays both physiological and pathological roles in numerous 
processes including adaptation to starvation, protein and organelle clearance, development, 
aging, elimination of microorganisms, cell death, tumor suppression and antigen presentation 
(115-118). 
 
1.2.1 Molecular mechanisms of autophagy 
Generally designated as Atg, more than 30 proteins have been implicated in autophagy 
regulation. Mammalian target of rapamycin (mTOR), the master sensor of metabolic status, 
inhibits autophagy under conditions of nutrient abundance (119-129). Other mediators of 
autophagic regulation identified to date include reactive oxygen species (ROS), B cell lymphoma 
2 (Bcl-2), AMP-activated protein kinase (AMPK), Ca2+, Bcl-2 and nineteen kilodalton 
interacting protein 3 (BNIP3), damage-regulated autophagy modulator (DRAM), calpain, tumor 
necrosis factor-related apoptosis-inducing ligand (TRAIL), Fas-associated death domain 
(FADD), and inositol triphosphate (IP3) (130-141). While the sources of autophagic membranes 
are cell and context specific, the ER is believed to be the major contributor along with the 
mitochondrial, plasma and nuclear membranes (142-144).  
Figure 2. Autophagy is a lysosome-dependent process responsible for the bulk degradation of organelles 
and long-lived proteins. Autophagy involves the encapsulation of cytoplasmic constituents into a double-
membraned structure called an autophagosome, which forms de novo in the cytosol. Mature autophagosomes fuse 
with lysosomes leading to the degradation of the inner membrane and sequestered cytoplasmic components by 
lysosomal hydrolases. Degradation products, including essential biological building blocks, are then recycled to 
the cytoplasm. 
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Phagophore initiation begins with the ULK complex, composed of ULK1/2, Atg13, 
FIP200, and Atg101, which is negatively regulated by mTOR complex 1 (mTORC1)-mediated 
phosphorylation (126, 145, 146). Nucleation is further supported by a class III 
phosphoinositol(3)kinase (PI3K), Vps34, which is recruited in a complex with Beclin-1, VPS15, 
UVRAG, Ambra1, and Bif1, and regulates lipid components at the forming autophagic 
membrane (Figure 3). Beclin-1 contains a BH3 domain, through which interaction with Bcl-2 
inhibits autophagy. Rubicon, another Beclin-1 interacting protein negatively regulates 
autophagosome-lysosome fusion (147-155). Two ubiquitin-like conjugation pathways promote 
autophagosome membrane elongation. Atg12 is covalently conjugated to Atg5 via activation by 
Atg7, an E1-like enzyme, and Atg10, an E2-like enzyme. Atg16L interacts with the Atg5-Atg12 
complex and dimerizes on the outer membrane promoting proper elongation and curvature of the 
isolation membrane (156-160).  Microtubule-associated protein light-chain 3B (LC3B) is 
conjugated to phosphatidylethanolamine and associates with both the inner and outer membrane 
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in the second conjugation system (Figure 3). LC3B is first hydrolyzed by Atg4A-D at the 
carboxyterminus revealing a terminal glycine residue, and can also be recycled from the outer 
surface of the autophagosome by similar proteolytic activity of Atg4.  LC3 and related proteins 
GATE16 and GABARAP are then activated and conjugated via Atg7, E1-like enzymatic 
activity, and Atg3, E2-like enzyme (161-166). Since LC3B remains associated with the 
completed autophagosome until lysosome fusion and is a substrate of degradation, this protein is 
frequently used as a marker of autophagosome formation and activity (167). Fusion of 
autophagosomes with lysosomes depends on the microtubule and actin cytoskeleton, as well as 
LAMP2 and the GTPase Rab7 (168-171). Upon hydrolytic degradation, amino acids are recycled 
to the cytoplasm by the putative amino acid effluxer Atg22, while mechanisms of carbohydrate 
and lipid recycling are not fully elucidated (172-174).    
 
Figure 3. Molecular mechanisms of autophagy. Greater than 30 proteins have been implicated in autophagy. 
Beclin-1 is a key component of the class III PI3K complex, which is required for autophagosome nucleation. 
LC3 is covalently conjugated to phosphatidylethanolamine on the inner and outer membranes of 
autophagosomes by the proteolytic activity of Atg4, followed by the ubiquitin ligase-like activity of Atg7 and 
Atg3. Selective autophagy is mediated by a growing number of adaptor molecules, including p62 and HDAC6. 
A ubiquitin binding domain and LC3 interacting domain allow p62 to recruit ubiquitinated proteins to the 
forming autophagosome. HDAC6 has ubiquitin and dynein binding domains, which promote efficient 
autophagic clearance of misfolded proteins by centralizing ubiquitinated aggregates. Furthermore, HDAC6 
mediated deacetylation of α-tubulin and cortactin regulate intracellular trafficking and autophagosome-
lysosome fusion, respectively. 
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1.2.2 Selective autophagy 
While autophagy was originally described as a nonselective process, a number of proteins, 
including p62/SQSTM1, histone deacetylase (HDAC) 6, neighbor of BRCA1 (NBR1) and Bag3 
confer specificity to autophagic cargos.  The chaperone protein Bag3 is upregulated with aging 
and promotes degradation of improperly folded proteins by autophagy (175-180). NBR1 was 
identified in a complex with Atg8, the yeast homologue of LC3B, in a yeast two-hybrid screen. 
NBR1 contains a conserved LC3 interacting motif, LIR, and an ubiquitin-binding domain. Both 
NBR1 and p62 localize to protein aggregates marking them for autophagic degradation, in a 
process by which these proteins are also selectively consumed (181-183).  
The selective autophagy protein p62 plays a critical role in the degradation of 
ubiquitinated proteins by autophagy, via an ubiquitin binding and LIR motif (Figure 3) (181, 
184). Also as a target of autophagic degradation steady state levels of p62 have been used to 
measure autophagic activity (185). Recently p62 was shown to be an important mediator of 
antioxidant activity via sequestration of Kelch-like ECH-associated protein 1 (Keap1) and 
release of Nrf-2 for transcription of proteins involved in antioxidant metabolism. From these 
studies p62 was shown to be transcriptionally regulated in a positive feedback loop by a Nrf-2 
antioxidant response element (186-190). Regulation of Nrf-2 by p62 has added an additional 
layer of complexity to the study of autophagy. For example, inhibition of autophagy promotes 
robust ubiquitinated protein accumulation. However, further analysis of knockdown of both 
autophagy and p62 relieved the accumulation, and Nrf-2 was implicated in directly upregulating 
components of the ubiquitin pathway (191, 192). Similarly, Atg7 chimeric knockout mice are 
predisposed to hepatic tumors, which are likewise relieved by p62 or Nrf-2 double knockout 
suggesting that tumor formation and survival in this model requires loss of autophagy as well as 
upregulation of antioxidant capacity (193).    
HDAC6 is another complex protein implicated at various stages of autophagy (Figure3). 
This protein is a cytoplasmic deacetylase with two catalytic deacetylase domains, a strong 
ubiquitin binding domain, and a dynein interacting domain (194-199).  Targets of HDAC6 
deacetylase activity include Hsp90, α-tubulin, peroxiredoxin and cortactin (196, 200-203). 
HDAC6 promotes efficient clearance of misfolded proteins by both concentrating substrates near 
the microtubule organizing center for autophagic degradation via ubiquitin binding and dynein 
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interactions, as well as assisting in autophagosome-lysosome fusion via deacetylation of the F-
actin interacting protein cortactin (198, 204-207). Finally, acetylation of α-tubulin is associated 
with long-lived microtubules, such as is the case for the microtubules of the ciliary axoneme 
(208, 209).  Microtubule acetylation enhances motor protein association, increasing the rate of 
trafficking and, while controversial, is generally believed to promote microtubule stability. 
Therefore, deacetylation and destabilization of microtubules by HDAC6 has been implicated in 
mediating intracellular trafficking and promoting growth factor induced cilia resorption (210-
212). 
1.2.3 Methods for detecting and monitoring autophagy 
There are many complimentary methods for monitoring autophagosome formation (213, 214). 
Due to their distinct double membrane structure, autophagosomes are easily identified 
morphologically by transmission electron microscopy (TEM) (215-218). Quality of membrane 
architecture as well as care to distinguish between true autophagosomes and cytoplasmic 
constituents proximal to ER is essential in this analysis. Quantification of autophagosomes can 
be reported as both a number per area as well as a percentage of cytoplasmic area.  
Since TEM provides a relatively small sampling of cells, immunofluorescence labeling is 
frequently employed (214, 219, 220). Endogenous labeling of LC3B, which remains associated 
with the autophagosome membrane from nucleation to lysosome fusion is most frequently 
utilized for autophagosome assessment. In these studies diffuse cytoplasmic LC3B staining 
becomes more punctate upon autophagosome formation. Regulation of autophagy genes and 
proteins are additional markers of autophagic activity. Immunoblot analysis of LC3, which 
migrates at a lower apparent molecular weight upon conjugation to phosphatidylethanolamine in 
association with the autophagosome membrane, is frequently used as an indirect marker of 
autophagosome numbers (221, 222). Since p62 is a direct target of autophagic degradation, a 
reciprocal relationship between protein levels and autophagic activity has been used in some 
studies (179, 223, 224).  
Autophagic flux, the rate of protein turnover by autophagy, is an important readout for 
any study, since autophagosome accumulation could reflect either enhanced autophagosome 
formation or inhibited lysosomal degradation. A construct of LC3B tagged with both GFP and 
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mCherry was generated to assess the proportions autophagosomes and autophagolysosomes. 
While autophagosomes fluoresce yellow, the autophagolysosomes appear red because the acidic 
environment denatures and quenches the GFP activity (194, 213, 214, 220). Care must be taken 
with these studies as overexpression of the GFP tag may lead to protein aggregation and puncta 
formation independent of autophagy (225). Autophagic flux assays can also be conducted by 
comparing the accumulation of autophagic substrates in control and treated conditions following 
inhibition of degradation in the lysosome. Inhibitors such as Bafilomycin A1, E64D, and 
chloroquine (CQ) prevent acidification of the lysosome, which is required for hydrolase 
activation. Leupeptin and pepstatin are specific inhibitors of lysosomal cathepsin activity. Using 
this approach, autophagic activity can be assessed both in vivo and in vitro (214, 219, 221, 226, 
227).  
1.2.4 Protein turnover in the lung 
Cellular catabolism in the lung was studied in detail 30 years ago. From these studies two 
distinct classes of proteins were characterized, short-lived and long-lived. The short-lived 
proteins were rapidly transcribed, labeled with the radioisotope within 10 min and were degraded 
at a linear rate of 11% per h, while long-lived proteins required several hours of labeling and 
were then degraded at a rate of 1-3% per h (228). While starvation was shown to nearly double 
the rate of long-lived protein degradation, metabolite excess, such as glucose or insulin 
administration, was able to suppress protein turnover (229). At the time autophagy was not a 
focus of these early studies; however, the dynamic response to stress and energy status are 
hallmark features of autophagic regulation.  
1.2.5 Autophagy in COPD 
Over twenty years ago autophagosomes were observed by TEM analysis of the respiratory 
epithelium of beagle dogs exposed to CS (230). In microarray analysis, Atg5 and LC3B were 
significantly upregulated in primary human airway epithelial cells differentiated at ALI and 
exposed to CS (73). Furthermore, links between metabolism, particularly autophagy-activating 
malnutrition, and lung destruction are also evident in the literature. Malnutrition in humans alone 
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is able to promote emphysematous changes in the lung (231-233). Similarly, the only mouse 
strains susceptible to CS induced emphysema are strains that fail to demonstrate the usual age-
related weight gain observed over 6 mo of chronic treatment (49). These data provide strong 
evidence implicating autophagy and metabolism in lung injury. 
The first papers exploring the role of autophagy in COPD demonstrated transcriptional 
upregulation of autophagy proteins in COPD patients, as well as, autophagosome accumulation 
that positively correlated with COPD severity (6, 8). In vitro and in vivo models indicated that 
autophagosome accumulation was an acute response to CSE treatment and preceded cell death. 
Interestingly, knockdown of Beclin-1 and LC3B in vitro protected cells from CS-induced cell 
death (6, 8). While the role of macroautophagy in directly executing cell death is a greatly 
debated, there is ample evidence for crosstalk between apoptosis and autophagy (234).  
The importance of disrupted protein folding homeostasis in airway epithelial cell stress 
has only recently moved to the forefront as a potential mediator of COPD pathogenesis. Recent 
studies have begun to elucidate the effects of CS on ER stress and protein turnover (66, 78, 79, 
235-237). In particular CS contains ROS, which interfere with proper protein folding in the ER 
and elicits UPR and ERAD (78, 79). During the process of ERAD misfolded proteins are 
ubiquitinated and targeted for degradation by the ubiquitin proteasome system (UPS) and 
autophagy (238, 239). In particular, misfolded proteins that accumulate are sequestered into 
inclusion bodies and aggresomes in the cytoplasm for efficient autophagic clearance (240, 241). 
Recently, ubiquitin positive aggregates have been observed in Gold stage 4 smokers. These 
findings are reminiscent of the inclusion bodies comprised of misfolded proteins observed in 
neurodegenerative disorders (237). In the lung, accumulation of misfolded proteins has been 
associated with increased production of inflammatory mediators by epithelial cells. These 
findings have led to the speculation that mutant A1AT may promote emphysematous changes 
through the accumulation of misfolded protein aggregates (242). Based on these observations, 
autophagy is implicated as a key mechanism for the degradation of misfolded proteins (243). 
Molecular mechanisms implicated in the upstream regulation of autophagy have also 
been correlated with the development of emphysema, in these studies CS was shown to inhibit 
mTOR via CS induced Rtp801 expression (7). While Rtp801 promoted inflammation, knockout 
mice were protected from CS induced inflammation, apoptosis and emphysema. Finally 
inhibition of mTOR directly promoted CS-induced proinflammatory pathways. While these 
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studies were not focused on autophagy, the finding of increased emphysema with mTOR 
inhibition, which activates autophagy, provides evidence for the relevance of these pathways in 
COPD.  
The autophagic response appears to be cell type specific. In studies focused on the role of 
autophagy in smokers’ macrophages, which are known to have reduced antimicrobial and 
enhance production of inflammatory mediators, autophagosomes accumulated due to decreased 
autophagic flux.  This defect led to accumulation of damaged mitochondria and decreased ATP 
levels and a greater dependence on anaerobic respiration (244). These studies implicate 
autophagy in COPD; however, the relationship is complex and far from completely elucidated.  
1.3 APOPTOSIS 
Apoptosis is a regulated cell death pathway characterized by cell shrinkage, breakdown of the 
cytoskeleton, formation of apoptotic bodies, loss of mitochondrial membrane potential and DNA 
fragmentation (245-250). Apoptosis is primarily executed by a cascade of cystein proteases, 
which specifically cleave at C-terminal aspartate residues. In the caspase cascade stimuli activate 
initiator caspases 2, 8, 9, and 10, which then cleave effector caspases 3, 6, and 7 responsible for 
cellular disposal.  
Intrinsic apoptosis is initiated by mitochondrial outer membrane permeability (MOMP), 
which is regulated by the Bcl family of proteins. Antiapoptotic members Bcl-2, Bcl-xL and Mcl-
1, containing BH 1,2,3,4 domains, reside on the mitochondrial surface and balance the 
proapoptotic BH1, 2, 3 members, Bak and Bax. The BH3-only proteins Bid, Bim, Bad, and Noxa 
sense and respond to cell stress and damage by activating BH1,2,3 proteins and neutralizing 
BH1,2,3,4 proteins. Upon activation of the cell death program proapoptotic Bcl proteins are 
thought to oligomerize to promote MOMP and the release of cytochrome c. Cytochrome C 
promotes caspase 9 activation via formation of the apoptosome, a complex consisting of 
apoptotic protease activating factor 1 (Apaf-1), procaspase 9, and dATP.  Caspase 9 cleaves and 
activates the effector caspases 3 and 7, which are responsible for execution of apoptosis.  A 
second mitochondria-derived protein Smac/Diablo promotes efficient caspase activity by 
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inhibiting the proteasomal degradation of effector caspases by inhibitor of apoptosis proteins 
(IAPs).     
Extrinsic apoptosis is regulated by cell surface receptors, including the tumor necrosis 
factor receptor (TNF-R) superfamily of death receptors and Fas. Upon TNFα or Fas ligand 
(FASL) binding the death inducing signaling complex (DISC) is formed by the recruitment of 
FADD and Caspase 8. DISC dimerization activates caspase 8, which directly activates caspase 3. 
FLIP is an endogenous inhibitor of caspase 8. Extrinsic and intrinsic apoptotic pathways 
converge upon caspase-mediated cleavage of the BH3 only protein Bid to tBid, which promotes 
MOMP. Both intrinsic and extrinsic apoptotic pathways have been implicated in COPD (251).   
1.3.1 Apoptosis in COPD 
Recent studies have demonstrated that apoptosis of epithelial, endothelial, mesenchymal, and 
inflammatory cells plays an integral role in COPD (252). Mouse models have shown that 
apoptosis leading to emphysematous changes can be induced without inflammation. For 
example, intratracheal administration of VEGF inhibitors, caspase 3, and ceramide are able to 
induce emphysematous changes in the lung via the direct activation of apoptotic pathways (253-
256). Inflammation associated with COPD also promotes apoptosis. Increased cytotoxic CD8+ T 
cells release perforins, granzyme B and TNFα (257-259). Unmitigated protease activity 
promotes matrix degradation, basal membrane detachment and anoikis (260). NE also cleaves 
the phosphatidylserine receptor of alveolar macrophages reducing phagocytic activity and 
allowing damaging apoptotic cells to accumulate (261). MMP7 activity produces cleavage 
fragments that activate FAS (262). Finally, oxidative stress promotes apoptosis, and CS induced 
cell death in vivo and in vitro can been abrogated by the application of antioxidants (58, 263, 
264). An apoptotic phenotype persists after smoking cessation in COPD patients indicating that 
this process may be an important therapeutic target (251, 265). 
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1.4 CROSSTALK BETWEEN AUTOPHAGY AND APOPTOSIS 
The intersection of autophagy and apoptosis as these two processes promote regulated cell death 
is complex. Attempts to simplify these pathways into two distinct cell death processes, generally 
fail to fully describe the effects of a given stimulus. Instead a model is now arising in which 
autophagy and apoptosis are considered different facets of the same cell death continuum rather 
than two separate processes (234, 266). However, depending on the cell context and stimulus, the 
processes may be mutually exclusive. Pure autophagic cell death occurs when cells die with an 
intact cytoskeleton, an accumulation of autophagosomes without the activation or requirement of 
the caspase cascade; however, this is a relatively rare observation. Proteins implicated in both 
autophagy and apoptosis can be regulated by the same upstream molecules, such as p53 and the 
PI3K/Akt pathway, which induce and inhibit both processes, respectively. Recently calpain and 
caspase-dependent cleavage of autophagy proteins has been rigorously described (267). Some of 
these autophagy protein cleavage fragments, particularly Atg5 and Beclin-1, amplify the 
apoptotic stimulus by translocating from the cytosol to the mitochondria and promote MOMP 
(139, 268-270). In addition Beclin-1 contains a BH3 domain through which it interacts with Bcl-
2 and Bcl-xL. This interaction at the ER membrane sequesters Beclin-1 away from the Vps34 
kinase complex required for phagophore initiation (155, 271, 272). While overexpression of Bcl-
2 inhibits autophagy, the overexpresion of Beclin-1 does not cause apoptosis (272). More 
recently we have published a role for caveolin-1 (Cav-1) in binding LC3B and Fas, thereby 
acting as a negative regulator of both apoptosis and autophagy (273). The interactions between 
apoptosis and autophagy proteins have proven to be both complex and at times contradictory, 
making this an exciting area of ongoing research.  
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2.0  RATIONALE & HYPOTHESIS 
Autophagy is an essential homeostatic process in which organelles and long-lived proteins are 
encapsulated in double-membraned autophagosomes and subjected to bulk degradation by fusion 
with lysosomes. Starvation and other stress pathways induce autophagic degradation in order to 
provide essential building blocks required for adaptation to stress. Certain stress stimuli are 
characterized by cell death with autophagosome accumulation and markers of injury are reduced 
by autophagy deficiency in these models. As a critical mediator of homeostasis and cell fate, 
autophagy has been implicated in the pathogenesis of numerous diseases from cancer to 
neurodegeneration (274-278). 
Recently, we determined that autophagy proteins are transcriptionally upregulated in 
COPD patients and that autophagosome formation is induced in in vivo and in vitro models of 
CS exposure. In these initial studies knockdown of autophagy proteins attenuated CS-induced 
cell death, while autophagy protein overexpression enhanced cell death (6, 8).  These findings 
imply that autophagy and autophagic proteins mediate the fundamental molecular response of 
lung epithelial cells to CS-induced stress; however, these studies focused on specific autophagy 
proteins and less on the process of autophagy. Three recent discoveries make the study of 
autophagy in mediating CS-injury challenging: 1) Autophagy proteins, particularly autophagy 
protein cleavage fragments generated by activated caspases and calpains, promote apoptosis 
independent of autophagic activity (139, 267, 270, 279). 2) Autophagy deficiency enhances 
oxidant capacity by increasing p62 sequestration of Keap1 and promoting Nrf-2 antioxidant 
transcriptional activity (188-190).  3) Misfolded protein aggregates, targets of autophagic 
degradation, have been implicated in the sequestration of autophagic proteins (280, 281).  These 
data suggest that autophagy and autophagy proteins may play a dual role in the response of 
epithelial cells to CS. Based on these observations we hypothesized that autophagy is a crucial 
mediator of cell fate in response to CS, promoting cellular homeostasis and adaption 
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during the initial cellular response, but instigating cell death during excessive or sustained 
CS exposure.  
 
 
This hypothesis is addressed in the following specific aims: 
 
1. To develop an in vitro model of the effects of CS on the airways 
 
2. To assess the effects of CS on autophagic activity in vitro and in vivo 
 
3. To examine the effects of CS on autophagic substrates  (i.e. misfolded and ciliary 
proteins) using HDAC6-/Y cells and mice 
 
4. Investigate the function of LC3B and Beclin-1 in autophagic and apoptotic pathways 
following CS exposure  
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3.0  MATERIALS AND METHODS 
3.1 REAGENTS 
Filtered research-reference cigarettes (3R4F) were obtained from The Tobacco Research 
Institute, University of Kentucky, Lexington, KY.  Ham’s F-12 with L-glutamine and DMEM/F-
12 without L-glutamine and HEPES (MT-10-080-CM and MT-15-090-CM) were purchased 
from Cellgro by Mediatech Manassas, VA. Deoxyribunuclease I from bovine pancrease 
(DNase1, DN25-100MG), retinoic acid (R2625-50MG), HEPEs 1M in H20 (83264-100ML), 200 
mM L-glutamine (G7513-100ml), Insulin from bovine pancreas (I6634-50MG), human apo-
transferrrin (T1147-100MG), SigmaFast Protease inhibitor cocktail tablets EDTA Free (S8830), 
leupeptin hemisulfate salt (L2884) and cholera toxin from Vibio cholerae (C8052-1MG) were 
obtained from Sigma-Aldrich, St. Louis, MO. Pronase from Streptomyces griseus (1016593100) 
was obtained from Roche, San Francisco, CA. Complete protease inhibitor cocktail tablets with 
EDTA (11 697 498 001) were purchased from Roche Diagnostics, Indianapolis, IN.  Collagen I, 
mouse epidermal growth factor (EGF; 354001), bovine pituitary extract (354123), Nu-Serum 
(355100), and Primaria Falcon 100 mm cell culture dishes (353803) were obtained from BD 
Biosciences, San Jose, CA. Bovine serum albumin (BSA; BP1605-100), amphotericin 
B/fungizone (1672346), 12 mm Transwell with 0.4 µm pore polycarbonate membrane (3401) 
and 12 mm Transwell with 0.4 µm pore polyester membrane (3460) were obtained from 
Corning Inc Costar, Lowell, MA. Cell culture antibiotics penicillin/streptomycin (10,000U) were 
purchased from Lonza, Walkersville, MD. Dulbecco’s Modified Eagle Medium with High 
Glucose (DMEM, 11965), phosphate buffered saline (1X; 10010), and gentamicin reagent 
(50mg/ml; 15750-060) were purchased from Invitrogen, Gibco, Auckland, NZ. TEM and SEM 
grade paraformaldehyde and gluteraldehyde were purchased from Electron Microscopy Sciences, 
Hatfield, PA. Histology grade formaldehyde, 37% solution was purchased from Mallinckrotd 
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Baker, Inc., Phillipsburg, NJ. Antibodies purchased from Santa Cruz Biotechnology, Santa Cruz, 
CA: acetyl α-tubulin (sc-23950), Beclin-1 (sc-11427), Bcl-2 (sc7382), Bax∆21 (sc-6236). 
Antibodies from Sigma-Aldrich: LC3B (L7543), p62 (P0067), β-actin (A2228). Antibodies 
purchased from Cell Signaling Technology, Beverly, MA: LC3B (27735S), cleaved caspase 3 
(9661S). Beclin-1 (612112) C-terminal specific antibody was purchased from BD Transduction 
LaboratoriesTM, Sparks, MD. Centrin-1 (ab11257) antibody was acquired from Abcam, 
Cambridge, MA. Horseradish peroxidase (HRP) -conjugated secondary antibodies for 
immunoblot analysis were purchased from Santa Cruz Biotechnology:  goat anti-rabbit IgG-HRP 
(sc-2004), goat anti-mouse IgG-HRP (sc-2005). Immunofluorescence reagents secondary 
antibodies Cy3-conjugated donkey anti-rabbit (711-165-152) or anti-mouse (715-165-150) 
were from Jackson ImmunoResearch Laboratories, Inc., West Grove, PA. Alexa Fluor 488 
(A12379) and 647 (A22287) conjugated to phalloidin and Alexa Fluor 488 secondary antibody 
anti-rabbit (A11034) and anti-mouse (A10667) and were purchased from Invitrogen, Molecular 
Probes, Eugene, OR. Remaining standard laboratory reagents were purchased from Sigma-
Aldrich. 
3.2 ANIMALS 
Beclin-1+/- mice were provided by Beth Levine (The University of Texas Southwestern Medical 
Center at Dallas, Dallas, TX). The HDAC6-/Y mice were provided by Bin Shan (Tulane 
University, New Orleans, LA). LC3B-/- were provided by Marlene Rabinovitch (Stanford 
University, Stanford, CA), and backcrossed into a pure C57BL/6 background in our laboratory. 
The GFP-LC3B mice were purchased from Riken BioResource Center (3-1-1 Koyadai, Tsukuba-
shi, Ibaraki 305-0074, Japan). WT C57BL/6 and Cav-1-/- were purchased from Jackson 
Laboratories (Bar Harbor, ME). All animal experimental protocols were approved by the 
Harvard Standing Committee for Animal Welfare or the University of Pittsburgh Institutional 
Animal Care and Use Committee. 
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3.3 IN VIVO CS EXPOSURE AND HARVEST PROTOCOL 
Age and sex matched mice starting at 6-12 wk of age were exposed to total body CS in a 71 cm 
X 61 cm X 61 cm stainless steel chamber using a smoke machine (Model TE-10 Teague 
Enterprises) 5 d/wk for 1wk, 2 mo, and 6mo or room air (RA). The CS treatment required 
approximately 2 h each day as the mice were exposed to the mainstream and sidestream smoke 
of 100 3R4F cigarettes with an average TPM of 150 mg/m3. The carboxyhemoglobin levels were 
typically less than 8% following exposure. Mice were also exposed to CS from 4 unfiltered 
cigarettes 5 d/wk using the nose-only method.  At the end of the exposure regiment mice were 
euthanized by CO2. The left lung was isolated with a suture, dissected and flash frozen in liquid 
nitrogen. The mouse was then tracheally cannulated and the right lungs were inflated with 2% 
formalin in PBS at 25 cm of H20 pressure, dissected from the mouse and fixed in 4% formalin at 
4°C for 2 d. The proximal trachea up to the larynx and a portion of proximal portion of the left 
lung were fixed for TEM analysis. 
3.4 LUNG MORPHOMETRY 
Lungs fixed for histology were further processed for morphological analysis of airspace 
enlargement by paraffin-embedding of midsaggital sections. Following a modified Gills staining 
10-12 random 20X fields were imaged and processed to remove large airways, blood vessels and 
other nonalveolar structures.  Images were acquired using brightfield microscopy on a Leica DM 
LB using a DFC480 3CCD Color Vision Module camera (Buffalo Grove, IL). The mean linear 
intercept was determined using a previously described algorithm, which has been automated in a 
modified ImageJ program available on the National Institute of Health website 
(http://rsb.info.nih.gov/ij/) (282-284).  
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3.5 CELL CULTURE AND CSE TREATMENT 
Beas-2B cells, a human lung epithelial cell line, were maintained in complete media DMEM 
supplemented with 10% fetal bovine serum (FBS) and gentamicin (50 µg/mL). Cigarette smoke 
extract (CSE) was prepared using a peristaltic pump (VWR International) to bubble mainstream 
smoke from four 3R4F cigarettes with filters removed through 40 mL DMEM. Each cigarette 
was smoked within 6 minutes until approximately 17 mm remained. The extract was adjusted to 
a pH of 7.5 filter sterilized, stored at -80°C, and used immediately upon thawing. The CSE 
generated in this fashion was considered 100% strength was diluted in complete DMEM for cell 
treatment. 
3.6 GENERATION AND CS EXPOSURE OF MTEC CULTURES 
Methods for MTEC isolation and culture generation were described previously (71, 285, 286). 
For each isolation, age and sex matched mice 6-12 wk were euthanized by CO2 necrosis. The 
tracheae were isolated and stored on ice in Ham’s F-12 containing antibiotics (1X 
penicillin/streptomycin and fungizone).  Careful dissection was used to remove all connective 
tissue and the tracheae were cut longitudinally to expose the luminal surface for overnight 
digestion at 4°C in 0.15% pronase in Ham’s F-12 with antibiotics. Six tracheas were digested in 
10 mL of solution in a 50 mL conical tube. The next day the tracheal digests were inverted 12 
times and allowed to incubate for an additional hour at 4°C. The enzymatic activity was stopped 
by adding 10 mL of Ham’s F-12 containing 20% FBS and antibiotics and gently inverted 12 
times. The tracheae were spooled onto a pasture pipette and transferred to a new 15 mL conical 
tube containing 10 mL of Ham’s F-12 with 20% FBS and antibiotics and inverted 12 times. This 
mechanical disruption of the tracheas was repeated two times more using fresh 15 mL conical 
tubes and media. Finally, the tracheae were discarded and the contents of the three 15 mL tubes 
were collected in the original 50 mL conical tube. The cells were pelleted at 350 xg for 10 min at 
4°C. The media was aspirated and the cells were incubated for 5 min on ice in 100-200 µL per 
trachea of DNase solution (0.5 mg/ml DNase, 10 mg/ml BSA, in Ham’s F-12 with antibiotics). 
The cells were then pelleted at 350 xg for 5 min at 4°C and then the media was aspirated. The 
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cells were seeded onto 100 mm Primaria plates in MTEC Basic Media (1 M Hepes, 200 mM 
Glutamine, 7.5% NaHCO3, 0.25 µg/ml Fungizone, 102 U/ml Penecillin Streptomycin in 
DMEM:Ham’s F-12) containing 10% FBS and incubated for 5-6 h in a humidified incubator at 
37°C, 5% CO2. Cells that did not attach to the plate were collected by centrifugation at 350 xg 
for 10 min at 4°C and the cells were resuspended in MTEC proliferation media (10 µg/µl insulin, 
5 µg/ml transferrin, 0.1 µg/ml cholera toxin, 25 ng/ml epidermal growth factor, 30 µg/ml bovine 
pituitary extract, 10X10-8 retinoic acid, and 5% FBS in MTEC basic media). In the 12 well 
transwell dish 1.5 mL of MTEC proliferation media was added to the basal compartment and 75-
100 X103 cells/well were seeded in 500 µL onto the transwells, which were previously coated 
with 400 µl of 100 µg/ml type 1 rat tail collagen, incubated overnight, excess solution was 
aspirated and allowed to dry before washing twice with PBS. Cells proliferated for 10 d in 
submerged culture conditions with media changes every other day and fresh media made every 
fifth day. Cultures with a resistance over 1000 Ω/cm2, as measured using an ohmvoltometer 
(EVOM, World Precision Instruments, Sarasota, FL), were put at an ALI by removing all 
apical media and replacing the basal media with 750 µl of MTEC differentiation media (2% Nu-
Serum and 10X10-8 M retinoic acid in MTEC basic media) in the basal compartment. The 
cultures then differentiated for 14 d at ALI with media changes every other day. CS treatment 
was conducted in a custom designed humidified chamber (EMI Services, Glenwillard, PA) at 
37°C by exposing the cells for 10 min to 50 or 100 mg/m3 of mainstream CS from 3R4F 
research-reference filtered cigarettes.     
3.7 PROTEIN EXTRACT PREPARATION, IMMUNOPRECIPITATION AND 
IMMUNOBLOT ANALYSIS 
All protein extractions were done on ice with ice-cold homogenization buffer. Protein extracts 
were made by lysing and scraping cells using cell RIPA buffer (400 mM HEPES, 5 M NaCl, 0.5 
M EDTA, 1 M Na3VO4, 1 M NaF, 100 mM glycerol 2-phosphate, 3% Chaps w/v) or for tissues, 
tissue RIPA buffer (300 mM NaCl, 50 mM Tris(pH 7.6), 1% NP-40, 10% glycerol, 1 mM 
EDTA, 1 mM NaF, 1 mM Na3VO4) made with a fresh complete protease inhibitor tablet (Roche 
Diagnostics, Indianapolis, IN). The samples were homogenized by sonication 5 times 10 min (60 
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Sonic Dismembrator, Fisher Scientific). Cells were spun once for 20 min at 14,000 xg while 
tissue protein extracts were prepared by centrifuging 5 times 10 min each time at 14,000 xg and 
transferring to a new eppendorf for each consecutive centrifugation. The supernatants were 
collected after the final centrifugation and the protein concentrations were determined by a 
Coomassie Plus (Bradford) protein assay (Pierce Biotechnology Inc., Rockford, IL) by 
measuring the absorbance at 595 nm and linear regression form a BSA standard curve. The 
protein samples were then normalized using homogenization buffer. For co-
immunoprecipitations cell extracts were incubated with 1 µg of antibody into 500 µg of total 
protein in 500 µl and incubated overnight on a rotor at 4°C. Then the extracts were incubated 
with 20 µL of protein A-sucrose beads (Santa Cruz Biotechnology) for an additional 2 hours, 
spun down at 500 xg, and washed by resuspending and centrifuging 5 times in RIPA buffer. All 
protein extracts were made in 1X NuPage loading buffer, 20 µl were added to the 
immunoprecipitation samples, and then boiled for 10 min.  Approximately 10-50 µg of the 
protein samples were subjected to electrophoresis using a 4-12% SDS-polyacrylamide gel 
(Invitrogen, Carlsbad, CA). The proteins were electro-transferred onto polyvinylidene diflouride 
membrane (PVDF; Invitrogen). After the membranes were blocked in 5% nonfat milk in 0.2% 
Tris-buffered saline with 0.1% Tween 20 (TTBS) for 1 h at room temperature, the blots were 
incubated overnight at 4°C in primary antibodies diluted in TTBS. Membranes were washed 
three times for 5-7 min with TTBS, and incubated at room temperature for 2 h in the 
corresponding HRP-conjugated secondary antibody. Membranes were washed three times for 5-
7 min again in TTBS and developed with ECL reagent (Amersham Biosciences, Piscataway, 
NJ). 
3.8 IN VIVO AUTOPHAGIC FLUX ASSAY 
A detailed protocol for in vivo autophagic flux has been described previously (227). Briefly, 
mice exposed to CS or RA were given an intraperitoneal injection of 40 mg/kg leupeptin in 
pharmaceutical grade saline at 1 h or 24 h following last the last CS treatment. Control mice 
received an equal volume of the vehicle. The leupeptin treated RA and CS mice were then 
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harvested 2 h later in parallel. Tissues were flash frozen and LC3B turnover was assessed in the 
lysosome-enriched (LE) fraction described section 3.9. 
3.9 TISSUE AND CELL HOMOGENIZATION TO OBTAIN A LYSOSOME-
ENRICHED FRACTION 
Subcellular fractionation for the LE fraction was previously described in detail (227). Briefly, 
tissues were flash frozen upon harvesting and stored at -80°C until processing, which was all 
done at 4°C or on ice. Cells were trypsinized and pelleted at 300 xg 8 min at 4°C. Lysates were 
made with homogenization buffer (10 mM Tris, pH 8.0, 5 mM EDTA, 250 mM sucrose, protease 
inhibitor tablet without EDTA). Cells were mechanically disrupted by dounce homogenization 
ten times with the loose and ten times with the tight pestle. The tissue was mechanically 
homogenized (7X95mm Saw Teeth Generator, Omni International The Homogenizer Company, 
Kennesaw, GA). The homogenate was then centrifuged at 700 xg for 10 min and transferred to a 
new tube. If debris was still present an additional 700 xg spin was implemented. The protein was 
then normalized to 1-2 mg/ml using the homogenization buffer. An aliquot was saved for the 
whole cell fraction. The sample was then centrifuged at 20,000 xg for 30 min. Supernatant was 
saved for the cytoplasmic fraction. The pellet was washed twice with homogenization buffer and 
resuspended in sample buffer. All cell fractions were prepared with 1X NuPage LDS sample 
buffer (NP007, Invitrogen, Carlsbad, CA) boiled for 10 min and subjected to subsequent 
immunoblot analysis. 
3.10 IN VITRO AUTOPHAGIC FLUX ASSAY 
Cells were exposed to CS or CSE and treated 10 min later with lysosome acidification inhibitors 
chloroquine (25 µM) or bafilomycin A1 (100 nm). Control cells were treated with the inhibitor 
without CS or CSE treatment. The samples were then harvested using cell RIPA buffer from 
control and treated cells at the same time 0, 1, 3, or 6 h later and analyzed by standard 
immunoblot analysis described in section 3.7. 
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3.11 CELL VIABILITY AND CYTOTOXICITY ASSAYS 
Cell viability was determined by the 3-(4-5-dimethylthiaxol-2-yl)-2,5-diphenyl tetraxolium 
bromide (MTT) assay.  Cytotoxicity was assessed by measuring lactate dehydrogenase (LDH) 
activity in the basal media of the MTEC cultures according to the manufacturer’s protocol 
(Cytotoxicity Detection KitPLUS, Roche Diagnostics, Indianapolis, IN).  This assay measures 
LDH released into the media upon plasma membrane permeability, the assay determines LDH 
content by a coupled enzymatic reaction in which the tetrazolium salt INT is reduced to 
formazan dye, which is measured at 500 nm. The assay was performed in duplicate in a 96-well 
format and the absorbance was measured using a Multiskan EX Microplate Photometer from 
Thermo Scientific (Waltham, MA). The Annexin V FITC Apoptosis Detection Kit was 
purchased from BioVision (Mountain View, CA). The assay was performed on both detached 
and attached cells, by collecting all detached cells and trypsinizing the attached cells, washing 
once with PBS, centrifuging at 200 xg and resuspending the cell pellet in the manufacturers 
assay buffer. The cells were then stained according to the manufacture’s protocol. The 
proportion of viable and apoptotic cells were assessed using a FACS Canto II (BD Bioscience) 
and FlowJo analytical software (Tree Star, Inc., Ashland, OR). 
3.12 INTRACELLULAR ATP ASSAY 
Intracellular ATP was assessed using the ATPlite luminescence assay system (Perkin Elmer, 
Waltham, MA). The assay measures light produced by the reaction of ATP with D-luciferin and 
luciferase. The amount of light produced is proportional to the ATP concentration. The assay 
was performed according to the manufacturer’s instructions with some scaling to accommodate 
the surface area of the transwells. Total protein was normalized and the ATP concentration in the 
cell lysis solution was quantified on luminometer (1420 Multilabel Counter, Victor3TM, Perkin 
Elmer, Waltham, MA) and determined by linear regression based on the standard provided in the 
kit.  
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3.13 SUCROSE-GRADIENT SUBCELLULAR FRACTIONATION 
Generation of sucrose gradient-derived fractions was described previously (249). Briefly, cells 
were lysed in ice-cold MBS buffer (25 mM Mes (pH 6.5), 150 mM NaCl, 1% Triton X-100, 1 
mM Na3VO4, with protease inhibitors). Lysates were adjusted to 4 mL of 40% sucrose by 
mixing with 80% sucrose and overlaid with 35% sucrose and 4 mL of 5% sucrose in MBS 
buffer. Twelve subfractions were obtained following ultracentrifugation at 39,000 rpm for 18 h 
(SW41 rotor, Beckman Instruments, Palo Alto, CA).  
3.14 DNA CONSTRUCTS 
Human WT LC3B cDNA (pCMV6-XL5-LC3B) was obtained from Origene (Rockville, MD), 
and mutagenesis was performed using the QuickChange II Site-directed Mutagenesis Kit 
(Stratagene-Agilent Technologies, La Jolla, CA). The Cav-1 WT (WT-Cav-1) expression clone 
and the Cav-1 CSD (residues 82-101)-deleted mutant (∆CSD) were gifts from C. Tiruppathi 
(University of Illinois at Chicago, Chicago, IL). The Fas wt and Fas C199S expression clones 
were kind gifts from M.E. Peter (University of Chicago, Chicago, IL). 
3.15 IMMUNOFLUORESENCE STAINING 
Cells were fixed with 4% paraformaldehyde in 1X PBS directly on transwells for 1 h at 4°C then 
washed with PBS and stored at 4°C. Staining was done following a standard protocol. The cells 
were permeabilized for 15 min in 0.01% Triton-X 100 then washed in PBS twice and 0.5% BSA 
in PBS twice. The cells were blocked for 45 min with 2% BSA in PBS. The cells were washed 
once in 0.5% BSA and then incubated for 1 h at room temperature in primary antibodies, LC3B 
(1:50) and acetylated α-tubulin (1:250). The samples were washed 5 times with 0.5% BSA and 
then incubated for 1 h at room temperature in secondary antibody, Alexa 488 anti-rabbit 
(1:1000), Cy3 anti-mouse (1:500) and or phalloidin conjugated to Alexa-647 or Alexa-488 
(1:1000). Misfolded protein aggregates were stained using a recently developed dye, ProteoStat 
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Aggresome Detetction kit for flow cytometry and microscopy, ENZO Life Sciences, 
Farmingdale, NY. The cells were washed 3 times with 0.5% BSA and then twice with PBS. 
Nuclei were then stained with Hoechst for 30 s and washed 3 times with PBS. The samples were 
then mounted onto slides using and imaged using epifluoresence (Leica DM LB microscope and 
DFC 480 3CCD Color Vision Module) or confocal (Zeiss LSM 510 with two-photon).   
3.16 TRANSMISSION ELECTRON MICROSCOPY 
Cells were fixed for 1 h and tissues were fixed overnight at 4°C using TEM grade fixative 
solution of 2% formaldehyde and 2.5 % glutaraldehyde in 0.1 M Sodium Cacodylate buffer, pH 
7.4. The samples were washed and stored in 0.1 M cacodylate buffer and kept at 4°C until 
processing. Sample embedding followed a standard protocol, in which all steps were done at 
room temperature unless otherwise indicated. The samples were post-fixed for 1 h in the dark in 
1% osmiumtetroxide / 1.5% potassiumferrocynide in H2O. The samples were washed 3 times in 
H20 or maleate buffer pH 5.15, then incubated in 1% uranyl acetate in H2O or maleate buffer for 
30 min. The samples were washed three times in H20 and dehydrated by a graded series of 
ethanol: 70% for 15 min, 90% for 15 min, then 100% twice for 15 min. The samples were then 
further dehydrated in propyleneoxide for 1 h. Infiltration was done with a 1:1 ratio of 
Epon:propyleneoxide for 2-3 h. The samples were then embedded in freshly mixed Epon and 
polymerized 24-48 h at 60°C. Ultrathin sections were then absorbed onto hydrophilic 
formvar/carbon coated grids and negatively stained with 1-2% aqueous uranyl acetate, dried and 
imaged using a Technai G2 Spirit BioTWIN transmission electron microscope. 
3.17 SCANNING ELECTRON MICROSCOPY 
MTEC cultures were washed with PBS twice with gentle agitation on a vortex to disrupt mucus 
coating then fixed for 1 h at 4°C in 4% paraformaldehyde in 1X PBS (pH 7.4). The samples were 
then washed thoroughly in three changes of PBS and stored at 4°C. The tissue was post fixed in 
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1% osmiumtetroxide for 1 h then washed three times with PBS. The samples were dehydrated in 
a graded series of ethanol by 15 min incubations with: 30%, 50%, 70%, 90%, and three times at 
100%. The samples were then critical point dried and mounted onto studs with the epithelial cell 
layer facing upwards and then sputter coated and stored in the desiccator. Specimens were 
imaged with a JEOL 9355 Field Emission Zeiss Gun scanning electron microscope with 
backscatter detector. 
3.18 STATISTICAL ANALYSIS 
Statistical analysis was conducted using GraphPad Prism software (GraphPad Software, La Jolla, 
CA). Data are presented as the means ± standard deviation (SD) or standard error of the mean 
(SE) from at least three independent experiments. Differences in measured variables between 
experiment and control groups were assessed using the Student’s t test and between multiple 
groups and conditions using one-way and two-way ANOVAs and Bonferroni post tests. 
Statistically significant differences * p<0.05, highly significant differences **p<0.01 and very 
highly significant differences ***p<0.005 are indicated.  
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4.0  RESULTS- DEVELOPMENT OF A PHYSIOLOGICAL MODEL OF CS-INDUCED 
CELL INJURY IN THE AIRWAY EPITHELIUM 
4.1 MTEC CULTURE GENERATION, CHARACTERIZATION, AND CS 
TREATMENT 
Since airway-derived immortalized cell lines lose the ability to differentiate into the various cell 
types lining the respiratory tract, C57BL/6 MTECs were isolated and grown at an ALI to 
produce highly differentiated pseudostratified cultures. This method was adapted from 
previously described protocols, in which cultures were created by digesting mouse tracheas with 
pronase, subjecting all detached cells to a brief negative selection step for fibroblasts, and then 
seeding the epithelial cell population onto transwells (71, 285, 287). In this study, cells 
proliferated under submerged conditions for 10 d and differentiated for an additional 14 d at an 
ALI (Figure 4A). Apical exposure to air is critical for differentiation and also induces fibroblast 
cell death, thereby ensuring culture homogeneity. Transepithelial electrical resistance (TER) was 
monitored every other day following seeding and used as a measure of culture confluence, 
purity, and differentiation. As the cells form an intact pseudostratified epithelium the TER 
peaked at approximately 3500 Ω/cm2 just following conversion to an ALI, then the resistance 
dropped and stabilizes to approximately 2500 Ω/cm2 as the cells differentiate and acquire ion 
channels (Figure 4B). MTECs that achieve a TER greater than 1000 Ω/cm2 are confluent 
enough to be put at an air-liquid interface, while resistance measurements below 1000 Ω/cm2 
after day 10 are generally indicative of fibroblast or microbial contamination (285, 287). 
Therefore, TER was measured prior to removal of the apical media and just before CS-exposure 
on day 24 to ensure the quality and consistency of the cultures in every experiment.  
Twenty-four days after seeding, ciliated, non-ciliated and basal cells were observed in the 
cultures by transmission electron microscopy (TEM) (Figure 4C). While the cells differentiated 
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into the correct representative cell populations, the morphology is more cuboidal than columnar. 
Ciliated cells comprised about 25% of the total cell population present in the MTEC cultures, 
which is consistent with previously published literature (285, 287). Goblet cells were also 
present in these cultures, but were rare, and with the other respiratory secretory cells were able to 
produce a discernable mucus layer; therefore the apical surface was also gently washed with 
fresh media during each media change, in particular, the apical surface was washed and the 
media changed at least 10 h prior to CS exposures.  
MTEC cultures with the culture plate cover left on were exposed to mainstream CS for 
10 min in a custom designed humidified chamber at 37ºC (Figure 4D). The average total 
particulate matter (TPM) achieved in the chamber during treatment was 50 mg/m3 or 100 mg/m3, 
Figure 4. MTECs that have proliferated on transwells and differentiated at an ALI are a physiologically 
relevant in vitro model of the respiratory epithelium. A) MTEC culture generation requires cell proliferation 
under submerged conditions for 10 d, followed by removal of apical media and differentiation at an ALI for 14 d. 
B) Cells were treated with mainstream CS in a custom designed humidified chamber at 37ºC. Cells were either 
treated once for 10 min with 50 or 100 mg/m3 of CS and harvested at 1, 4, 8, 24 h or treated up to 3 days with 50 
mg/m3 and harvested at day 1, 2 and 3. C) Following seeding on day 0, TER was measured to monitor the 
confluence, purity and differentiation state of the cultures. D) TEM analysis of ALI cultures confirmed the 
formation of a pseudostratified epithelium with ciliated, basal, and non-ciliated cells. (a-ciliary axoneme, bb-
ciliary basal bodies, m-mitochondria, n-nucleus, s-substrate, mv-microvili; Bar=500nm) 
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generated by pumping in the mainstream smoke from 1 or 2 research-grade University of 
Kentucky 3R4F reference cigarettes, respectively. Following treatment, the cells were returned to 
a standard cell culture incubator with constant 37ºC, 5% CO2 and humidity. Cells were exposed 
to CS with either a single dose of 50 or 100 mg/m3 for 10 min or multiple doses 10 min each of 
50 mg/m3 every day for 3 d. In the single-dose model, cells were treated with CS and assessed at 
1, 4, 8 and 24 h following exposure. In the multiday chronic model, the cells were treated with 
CS once a day with 50 mg/m3 TPM over the course of three days and cells were harvested at 24, 
48 and 72 h following the first treatment (Figure 4D). Since MTEC cultures are highly 
differentiated and can be treated at the ALI with whole mainstream smoke, these cells represent a 
suitable model for studying the effects of CS on the respiratory epithelium, particularly ciliated 
cells. Additionally, cultures can be generated from transgenic or gene deleted null mice to study 
the functional role of a specific protein or pathway in the response of the airway epithelium to 
CS.  
4.2 CS-INDUCED DISRUPTION OF INTERCELLULAR CONTACTS AND CILIA 
Following CS treatment, MTEC injury was first assessed by fluorescence microscopy (Figure 
5A). Cells were stained for nuclei using Hoechst, F-actin using phalloidin conjugated to Alexa 
Fluor 488 and for cilia using Cy3 conjugated secondary antibody for acetylated α-tubulin, a 
posttranslational modification of long lived microtubules. While acetylated α-tubulin is not 
specific for cilia, acetylated α-tubulin is a sufficient cilia marker when combined with the distinct 
tuft-like morphology and apical localization of this organelle. F-actin is an integral component of 
both tight and adherens junctions; therefore, this stain delineates the nature of intercellular 
contacts. In control cells the ring of F-actin at the apical-basal junction was essentially 
continuous from one cell to the next and fields of ciliated cells were present. Four hours after 
treatment with 100 mg/m3 of CS, dramatic remodeling of intercellular contacts was apparent, as 
the F-actin became discontinuous between neighboring cells and the intensity of staining 
increased. By 24 h, the F-actin stain indicated that the cells were rounder and larger. Previous 
studies using an epithelial cell line, Calu-3, grown on transwells and treated with CS at an ALI 
showed that CS alters tyrosine phosphorylation of tight junction proteins (72, 288). Similarly, 
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adherens junction disruption by CSE treatment has also been investigated in human-derived 
primary cultures (77). These findings are in marked contrast to the intercellular junction 
remodeling in MDCK II cells, which upon treatment with chemicals to shed cilia, have increased 
resistance (289). Furthermore, microarray analyses of CS-treated human ALI cultures have 
shown a decrease in junction protein expression (73). These studies demonstrate the importance 
of crosstalk between cilia and tight junctions, which are markers and mediators of epithelial cell 
polarization.  
Immunofluorescence observations were further confirmed by scanning electron 
microscopy (SEM; Figure 5B). SEM of cells treated with 50 mg/m3 demonstrated that cilia 
injury induced by CS occurred independent of apparent intercellular junctional remodeling. 
These results imply that general loss of apical-basal polarity does not account for all cilia 
disruption in this model. Intercellular contact disruption was most apparent by SEM in cells 
treated with 100 mg/m3, in which cells appeared disconnected from one another and the matrix. 
Some cilia loss was apparent in these cells, but more pronounced was the complete loss of 
microvili, actin-based structures, observed on the surface of other epithelial cell types. These 
data support a significant impact of CS on cytoskeletal structures. Consistent with the above 
observations, CS-induced disruption of monolayer integrity was apparent in TER measurements, 
in which there was an acute drop in TER that fully recovered in cultures treated with 50 mg/m3 
TPM (Figure 5C). Cultures treated with 100 mg/m3 had a rapid and sustained loss of resistance. 
Control cultures maintained a resistance of ~2500 Ω/cm2 over the entire experiment. TER 
demonstrated a threshold effect, in which the pseudostratified epithelium either recovered to 
control levels, or resistance was completely lost without intermediate resistance measurements 
by 24 h following CS exposure. These data confirmed the time and dose dependent changes in 
intercellular contacts, and the recovery of intercellular contacts further demonstrated that CS-
induces a highly regulated change in the nature of intercellular contacts.  
Quantification of total ciliated cells remaining 24 h after CS exposure was determined by 
counting the number of acetylated α-tubulin cilia stained cells as normalized to total cells 
determined by counting nuclei in each field (Figure 5D). Based on these data, CS caused a dose 
dependent decrease in the percentage of ciliated cells; however, this method was not sensitive to 
changes in cilia length and number per cell. These data over accentuate changes in ciliated cell 
numbers caused by cell sloughing and failed to detect more subtle CS-induced cilia changes. 
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These data provide insights into the major morphological changes and regulated responses of 
epithelial cells exposed to CS. 
 
 
 
Figure 5. Acute exposure of MTEC cultures to CS disrupts intercellular contacts and induces cilia 
shortening and loss. A) ALI cultures were treated with CS at 100 mg/m3 TPM, fixed at the indicated times 
and then stained for nuclei (blue, Hoescht), F-actin (green, Alexa-488 conjugated phalloidin) and cilia (red, 
acetylated α-tubulin). Epifluorecence images were acquired at different focal planes of the same field at 
100X. (black arrows-disrupted intercellular contacts, white arrows- ciliated cells, white arrow heads-
shortened/injured cilia) B) MTEC cultures 24 h after treatment with the indicated CS TPM (mg/m3) were 
analyzed by SEM. (black arrows-disrupted intercellular contacts, white arrow-ciliated cells, white arrow 
heads-shortened/injured cilia, s-substrate; Bar=10 μm) C) Epithelial integrity was monitored by measuring 
TER at the indicated times after CS exposure. D) Percentage of ciliated cells was determined by 
quantifying the number of ciliated cells for total number of nuclei in 5-10 fields. TER and ciliated cell 
measures were assessed in 6 independent experiments and results are presented as the mean ± SE and 
*p<0.05 by student’s unpaired t test. 
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4.3 CS-INDUCED CELL DEATH IN MTEC CULTURES 
Cytotoxicity was assessed in MTECs treated with CS by assaying lactate dehydrogenase (LDH) 
activity in the basal media (Figure 6A). LDH activity was not detected in control cultures and 
cultures treated with 50 mg/m3 TPM, while an average of 700 mU of LDH activity was detected 
in cultures treated with 100 mg/m3. To correlate the levels of LDH activity to the proportion of 
cells undergoing late and early apoptosis, cells were trypsinized from the transwell membranes 
and collected with all detached cells and subjected to flow cytometry for the apoptotic indices, 
Annexin V (AV) and propidium iodide (PI) (Figures 6B & C). AV positive PI negative cells 
were considered early apoptotic cells and AV positive PI positive are cells were considered late 
apoptotic cells. While apoptotic cells were generally rare in the control MTEC cultures, the harsh 
conditions required for epithelial cell disassociation caused a marked increase in the cell death 
response; however, the difference between control and 50 mg/m3 TPM treated cells was not 
significantly different supporting the findings of the LDH assay. In contrast, the majority of cells 
treated with 100 mg/m3 entered either early apoptosis (~50%) or late apoptosis (~40%) (Figure 
Figure 6. Cytotoxicity induced by acute CS-exposure in MTEC 
cultures. A) LDH activity was assayed in the basal media 
following CS treatment with 50 or 100 mg/m3 TPM. Data are 
presented as the mean ± SE of three independent experiments; 
p<0.05. B) Twenty-four hours after CS exposure apoptosis was 
assessed by AV/PI staining and flow cytometry. C) Percentage of 
viable cells normalized to the control determined by AV and PI 
staining and flow cytometry. Flow cytometry results are the mean 
± SE of three independent experiments and statistical significance 
was assessed by one-way ANOVA with Bonferroni post test; 
**p<0.01 & ***p<0.001. 
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6B). The percentage of viable cells, Annexin V and PI negative, was determined relative to 
controls. Viability was maintained in cells treated with 50 mg/m3, while less than 15% of the 
cells were viable 24 h following exposure to 100 mg/m3 TPM (Figure 6C). These data indicate 
that this model is ideal for studying the effects of both subtoxic and toxic doses of mainstream 
CS on highly differentiated MTEC cultures. 
4.4  A CHRONIC MODEL OF CS TREATMENT 
To recapitulate the effects of chronic exposure to CS in the MTEC cultures, cells were treated 
with 50 mg/m3 for 10 min once a day over the course of 3 d and cultures were harvested 24 h 
after each smoke treatment. The morphology of the cells was again assessed by confocal 
microscopy at each time point after staining for nuclei, F-actin, and acetylated α-tubulin (Figure 
7A). There was a time dependent disruption of cilia as cells treated for multiple days appear to 
have fewer and shorter cilia by this analysis; however, intracellular contact disruption was only 
observed following CS treatment for 3 d, when large intercellular gaps became apparent. This 
observation was corroborated by loss of TER in the cultures treated with 50 mg/m3 on the third 
day (Figure 7B). While quantification of the percentage of ciliated cells after smoking is not a 
sensitive measure of CS-induced cilia shortening and loss, there was a statistically significant 
decrease in ciliated cells following 3 d of CS treatment (Figure 7C). Cytotoxicity over the 
multiple days of CS exposure was determined by measuring the LDH activity in the basal media 
(Figure 7D). LDH activity was not detected in control cells or cells exposed to CS for one and 
two days; however, a significant increase in LDH activity was detected 24 h after the third 
smoke exposure. In both the single and chronic CS exposures ciliated cell loss was only 
significant with the induction of cell death. These data present strong evidence for the role of 
epithelial cell sloughing in CS-induced ciliated cell loss, and also suggest that ciliated cells are 
more susceptible to CS-induced injury. These data are consistent with the basal cell population, 
which is protected underneath the ciliated and nonciliated cells, playing a critical role in re-
epithelialization following desquamation (290, 291).  
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Figure 7. Cilia loss, intercellular contact disruption and cytotoxicity are observed following 
multipule doses of CS at 50 mg/m3 TPM. A) Confocal analysis of MTEC culture z-sections stained 
for nuclei (blue, Hoescht), F-actin (green, Alexa488-conjugated phalloidin) and cilia (red, acetylated 
α-tubulin). (arrows-cilia, arrow heads-shortened/injured cilia, double arrows- disrupted intercellular 
contacts. B) TER was measured prior to CS exposure and then 24 h following CS exposure. C) Loss 
of ciliated cells in the MTEC cultures was observed following three continuous days of CS 
treatment. D) Cytotoxicity was assessed by measuring LDH activity in the basal media 24 h after CS 
exposure. All data are presented as the mean ± SE with statistical significance determined by 
student’s unpaired t test; *p<0.05 & **p<0.01.  
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5.0  RESULTS- EFFECTS OF CS ON AUTOPHAGY 
5.1 CS-INDUCED ACCUMULATION OF AUTOPHAGOSOMES IN MTEC 
CULTURES 
To investigate the effects of CS on autophagy in the respiratory epithelium, TEM was used to 
visualize autophagic structures in ciliated cells of MTEC cultures 24 h following CS treatment 
(Figure 8A). There was an increase in autophagosomes in cultures treated with 50 and 100 
mg/m3 TPM. The cells treated with the sublethal CS dose contained both autophagosomes and 
autolysosomes, while the cells treated with the acutely lethal dose appear apoptotic with an 
accumulation of autophagosomes and other vacuoles. Additionally, cultures treated with 100 
mg/m3 were completely devoid of ciliary axonemes, while the nucleating basal bodies remained 
docked at the apical surface. In order to confirm CS-induced autophagosome accumulation, 
MTEC cultures were generated from GFP-LC3B mice and treated with CS (Figure 8B & C). 
While there was a significant ~30% increase in GFP-LC3B puncta/µm2, a dose dependent 
accumulation was not observed. These imaging studies confirm that CS induces autophagosome 
accumulation in MTEC cultures. Autophagy and cell death markers were assessed by 
immunoblot analysis for LC3B II, p62, and cleaved caspase 3 (Figure 8D). Cultures treated with 
50 mg/m3 TPM had similar steady state levels of LC3B II and p62 as the control. In contrast, the 
LC3B immunoblot showed a rapid accumulation of LC3B II in cultures treated with 100 mg/m3 
TPM, which preceded induction of cell death as assessed by production of cleaved caspase 3. 
Furthermore, high molecular weight p62 positive aggregates were produced in cultures treated 
with 100 mg/m3 TPM. These SDS-insoluble aggregates appear in autophagy deficient cells and 
are frequently used as a marker of decreased autophagic flux (179, 224). 
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Figure 8. CS causes autophagosome accumulation in MTEC cultures. A) Autophagosomes (blue arrows) and 
autolysosomes (red arrows) accumulate in MTEC cultures treated with CS at the indicated TPM (mg/m3). 
Axonemes are completely absent in some ciliated cells treated with CS at 100 mg/m3 TPM. (a-axoneme, bb-basal 
bodies, m-mitochondria, bar=500nm). B) Representative images of MTEC cultures generated from GFP-LC3B mice 
show an accumulation of GFP-LC3 puncta. (bar=10μm) C) GFP-LC3B puncta were quantified in 10 fields at 63X 
magnification from three independent experiments and tested for significance by one-way ANOVA using 
Bonferroni post test **p<0.01, ***p<0.005. D) Autophagy and cell death markers were assessed in MTEC cultures 
by immunoblot at the indicated time points after treatment with 50 mg/m3 or 100 mg/m3 CS TPM. Cytoplasmic (I) 
and autophagosome-associated (II) LC3B bands, with apparent molecular weights  (kDa) are indicated to the right of 
the blots.  
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5.2 INDUCTION OF AUTOPHAGIC FLUX BY CS EXPOSURE IN MTEC 
CULTURES 
Steady state measurements of autophagosome accumulation and autophagy markers are unable 
to distinguish between autophagy induction and inhibition of lysosome fusion/degradation. To 
assess CS-induced changes in autophagic flux following a single treatment with 50 or 100 mg/m3 
TPM, accumulation of LC3B II and p62 were measured by immunoblot following the addition of 
the lysosome acidification inhibitor bafilomycin A1 (Figure 9A). As described previously, 
LC3B II, which coats both the inner and outer autophagic membrane, is degraded in the inner 
compartment following autophagosome lysosome fusion. The protein p62 is a target of 
autophagic degradation. Via an LC3 interaction motif, an ubiquitin binding motif and other 
protein interacting motifs, p62 selectively recruits other proteins for autophagic degradation. 
This activity of p62 is generally considered a complementary mechanism to the proteosomal 
pathway for the removal of ubiquitinated proteins. While control cultures and cultures treated 
with 50 mg/m3 TPM had a similar rate of LC3B II accumulation, LC3B failed to accumulate in 
cells treated with 100 mg/m3 TPM. These data indicated that overall flux was not changed in 
subtoxic CS exposure compared to control cultures, while flux is reduced in cultures in which 
cell death is acutely induced. The decrease in LC3B protein following bafilomycin A1 treatment 
likely reflected overall repressed transcriptional activity at this lethal dose of CS. The high basal 
level of autophagy in the control cells may be an artifact of the cell culture system, reflecting the 
surplus of nutrients available to these cells. Since the MTEC cultures are highly confluent, 
differentiated, and not highly proliferative, excess nutrients in the absence of proliferation may 
cause the cells to have high anabolic and catabolic activity, of which autophagy may play a 
critical role. In contrast to the rate of LC3B II accumulation by bafilomycin A1, p62 
accumulation was augmented in the cells treated with 50 mg/m3 TPM compared to control. The 
monomeric and SDS-insoluble p62 positive bands were both enhanced by CS exposure. 
Consistent with LC3B flux analysis, treatment with 100 mg/m3 TPM inhibited selective 
autophagic flux, and induced acute cytotoxicity marked by an accumulation of autophagosomes, 
LC3B II, and SDS-insoluble p62 by immunoblot (Figure 8D & 9A).  
Since autophagy is dependent upon ATP and mitochondria are particularly vulnerable to 
the oxidative stress caused by CS, ATP levels were measured in the MTEC cells following CS 
exposure to determine if lack of intracellular ATP could account for the block in autophagic 
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activity (Figure 9B). While there was a time dependent drop in cellular ATP, the kinetics of this 
drop were much slower and not significant compared to the acute block in autophagic flux 
observed with 100 mg/m3 TPM. These data indicate that the block in autophagic activity caused 
by lethal CS treatment is not a consequence of inadequate energy availability.  
To confirm these findings autophagic flux was also assayed in the multiday model of CS 
treatment using chloroquine (CQ), which also prevents lysosome acidification (Figure 9C). 
Consistent with the single dose studies LC3B II turnover was not altered, while p62 turnover was 
enhanced by CS treatment. The SDS-insoluble p62 positive aggregates appear with CQ treatment 
in the CS treated cells, which suggests that these aggregates are produced as a result of CS 
exposure and are efficiently cleared by autophagy. However, p62 is a target of the oxidative 
stress transcription factor Nrf-2, and CS-induced p62 transcription may increase the p62 
available for turnover and thereby contribute to the apparent increase in autophagic flux 
determined by this marker (188, 189, 191, 193, 292). These in vitro studies suggest that 
Figure 9. Autophagic flux is regulated by CS in a dose 
and time dependent manner in MTEC cultures.  
A) Representative immunoblot analysis of cultures treated 
with bafilomycin A1 (100 nM) in the basal media for the 
indicted times following CS exposure. B) Intracelluar ATP 
was assayed at the indicated time points following exposure 
to a single dose of CS of either 50 or 100 mg/m3 TPM. 
There was not a statistically significant difference in ATP 
levels between treatment groups at any of the time points 
assayed. C) Representative immunoblot data of MTEC 
cultures exposed to 50 mg/m3 CS and on the indicated day 
of harvest were treated with CQ (25 uM) in the basal media 
approximately 10 min after the smoke treatment and 
harvested 3 h later. Cytoplasmic (I) and autophagosome-
associated (II) LC3B bands, with apparent molecular 
weights  (kDa) indicated to the right of the blots. 
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autophagic flux, particularly selective autophagic flux, is activated by CS in two different models 
of subtoxic, 50 mg/m3 TPM CS treatment. These data also indicate that lethal doses of 100 
mg/m3 TPM CS cause autophagosome accumulation associated with decreased autophagic flux, 
which is independent of a loss in cellular ATP and precedes detection of cell death markers.  
5.3 INDUCTION OF AUTOPHAGIC FLUX BY CS IN VIVO 
To validate the in vitro findings of the MTEC cultures treated with CS, mice were treated with 
CS for 1 wk or 2 mo and assessed for autophagic markers. Mice were exposed to CS 5 d/wk for 
approximately 2 h a day in a total body box in which the TPM was between 150 and 200 mg/m3. 
TEM analysis of the tracheal epithelium of mice treated for 1 wk with CS contained ciliated cells 
which recapitulated the phenotypes observed in both the 50 and 100 mg/m3 TPM treated MTEC 
cultures (Figure 10A). While the majority of cells contained autophagosomes and appeared 
viable as would approximate the sublethal treatment with 50 mg/m3, an occasional apoptotic cell 
was observed that resembled the cells in the MTEC cultures treated with 100 mg/m3. In these 
apoptotic cells intercellular contacts were disrupted, basal bodies docked at the apical membrane 
were devoid of axonemes, mitochondria were swollen, the cells were filled with vacuoles and 
there was evidence of nuclear condensation. Based on this imaging analysis, the MTEC cultures 
treated with CS appear to closely approximate the effects of CS on the respiratory epithelium in 
vivo. Mice treated with CS for 1 wk or 2 mo were injected with the lysosomal protease inhibitor 
leupeptin either immediately following (t=0h) or 24 h (t=24h) after the final CS treatment and 
tissues were harvested 2 h later, in order to assess the effects of CS on autophagic flux in vivo 
(Figure 10B). LC3B accumulation in the lysosome-enriched (LE) fraction was then compared 
between control and CS treated mice by densitometric analysis. The difference in LC3B levels 
for each mouse was calculated from an LC3B standard curve and the difference in flux between 
the room air (RA), 1 wk, and 2 mo CS treated mice was determined by subtracting the mean 
basal amount of LC3 in the PBS treated mice for each treatment group form the individual values 
of the leupeptin treated mice. The difference in LC3B was then graphed to show the change in 
LC3B II turnover in the LE fraction caused by CS. There was a time dependent increase in 
autophagic flux activated by CS exposure, as the 2 mo CS mice had the most autophagic flux. 
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The LC3B II levels in the PBS treated 2 mo CS mice was lower than the RA, suggesting that 
there are fewer autophagosomes accumulating in the lung tissue of these mice with this 
treatment. Finally, CS-induced autophagy was sustained as flux was significantly increased 
whether the activity was assayed immediately after exposure or 24 h later in the 2 mo CS treated 
mice. 
 
Figure 10. CS regulates autophagic activity in vivo. A) Representative TEM images show both 
morphologically healthy and dying cells, as well as autophagosome morphology in ciliated cells of the 
tracheae of mice exposed to RA or to CS for 1 wk (arrows-autophagosomes, a-axoneme, bb-basal bodies, 
m-mitochondria, n-nucleus. Bar=500nm). B) Mice exposed to CS for 1 wk or for 2 mo were injected with 
40 mg/kg of leupeptin immediately following the last CS exposure (t = 0h) or 24 h later (t = 24h). Whole 
lungs were harvested and frozen 2 h subsequent to the leupeptin injection. Autophagic flux was assessed by 
densiometric analysis using an LC3B standard curve, following the isolation of the LE fraction. Flux was 
calculated by subtracting the average amount of LC3B II in vehicle treated mice from the amount of LC3B 
II that accumulated with leupeptin treatment (n=3-4, *p<0.05 by students unpaired t test).  
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6.0  RESULTS- EFFECTS OF CS ON AUTOPHAGIC SUBSTRATES 
6.1 EVIDENCE FOR PROTEIN AGGREGATE STRESS IN PATIENTS WITH COPD 
Recent studies have suggested that misfolded protein stress promotes proinflammatory pathways 
contributing to COPD pathogenesis (237). In one of these studies expression of mutant A1AT 
was shown to enhance inflammatory cytokine production; suggesting that this mutation may 
promote emphysematous phenotype by an additional mechanism to altering the lung protease 
balance (237, 242, 243). More recently a survey of COPD patients’ lung tissue for markers of 
UPR and ERAD, demonstrated a marked accumulation of ubiquitinated aggregates in late 
disease (237). Since protein folding may be a key molecular mechanism underlying CS-induced 
changes in epithelial cells and autophagy is a critical mechanism for protein aggregate removal, 
we investigated this pathway in human tissues. Using ProteoStat™ protein aggregation dye to 
stain protein aggregates, also called inclusion bodies, we observed an increase in cells containing 
large numbers of red staining puncta, which positively correlated with COPD severity (Figure 
11A) (293). These findings are in agreement with the recently published paper in which ubiquitin 
positive aggregates were observed in late stage COPD. Furthermore, expression of HDAC6, 
which has been implicated in efficient autophagic degradation of protein aggregates, was also 
significantly upregulated in the lungs of smokers, but was not correlated to COPD severity 
(Figure 11B). These findings suggest that pathways implicated in protein aggregate removal 
may be upregulated in smokers as a fundamental physiological response to CS. These data 
support a role for protein aggregate stress in COPD pathogenesis and suggest that inefficient 
removal of protein aggregates may be a hallmark feature of late stage disease. 
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Figure 11. Misfolded protein aggregates accumulate in late stage COPD patients and HDAC6, a 
protein critical for aggregate removal, is acutely upregulated in smokers. A) Protein aggregates 
were stained in human lung tissue using ProteoStat™ protein aggregation assay from ENZO. Protein 
aggregates (arrows) appear in both the airway and parenchyma tissue of COPD patients. Nuclei (blue) 
were stained with Hoechst. Representative confocal images acquired at 63X. B) HDAC6 expression in 
human lung tissue was determined by densiometric analysis of immunoblots. Data are mean ± SE of 4-
5 samples and statistical analysis was performed by student’s unpaired t test compared to the never 
smoker control. 
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6.2 HDAC6 DEFICIENCY PROMOTES CS-INDUCED ACCUMULATION OF 
MISFOLDED PROTEIN AGGREGATES 
To determine if CS induces misfolded protein accumulation in epithelial cells, ProteoStat™ 
protein aggregation dye was used to assay for protein aggregates in MTEC cultures treated with 
50 and 100 mg/m3 CS TPM (Figure 12A). A dose dependent induction of inclusion bodies was 
observed in these cultures, suggesting that CS is a potent inducer of misfolded protein stress. 
Since HDAC6 promotes autophagic degradation of protein aggregates and is upregulated in 
response to CS in the lung, we investigated the importance of this protein using HDAC6-/Y 
derived MTEC cultures (198, 206, 207). Consistent with these previous findings, HDAC6-/Y 
cultures contained more inclusion bodies basally and following CS treatment compared to 
controls (Figure 12A). Despite these differences, MTEC cultures generated from these mice 
appeared to have similar disruption of culture integrity following CS-treatment. There were no 
statistically significant differences in resistance in the HDAC6-/Y or HDAC6+/Y at baseline or 
following CS exposure (Figure 12B). These data indicate that this protein does not play a critical 
role in the events leading to CS induced cell-cell contact disruption. Surprisingly, immunoblot 
analysis of the MTEC cultures revealed low baseline activation of apoptosis in the HDAC6-/Y 
cultures by cleaved caspase 3 immunoblot; however, cell death following lethal treatment with 
100 mg/m3 CS TPM was slightly abrogated in these cells (Figure 12C). The simplest 
interpretation of these data would be that HDAC6 plays an as yet unknown role in CS-induced 
cell death, possibly by potentiating CS-induced autophagic cell death pathways. Consistent with 
the wildtype cultures being more injured by 100 mg/m3 CS, p62 SDS-insoluble aggregates and 
Beclin-1 cleavage associated with cell death, were more abundant in the HDAC6+/Y cells. 
Finally, since HDAC6 plays a critical role in primary cilia regulation expression of the cilia 
marker centrin-1 was also investigated in these cultures (210). While this cilia marker was 
depleted in the HDAC6+/Y cultures treated with 100 mg/m3 CS TPM, the HDAC6-/Y cells 
appeared protected. These data indicate that HDAC6 plays a critical role in cellular homeostasis 
and the removal of misfolded proteins by autophagy. While the HDAC6-/Y cells appeared 
vulnerable to cell death basally, the abrogation of apoptosis following lethal CS treatment 
suggests a specific function in the execution of CS-induced cell death.  
 48 
       
 
 
 
Figure 12. Increased baseline cell death and misfolded protein accumulation in HDAC6-/Y MTEC 
cultures. A-C) Analysis of MTEC cultures 24 h after exposure to the indicated concentrations of CS TPM 
(mg/m3) A) Protein aggregates (red) were stained in MTEC cultures using ProteoStat™ and nuclei (blue) 
were stained with Hoechst. Representative images were selected from fields acquired at 63X by confocal 
microscopy. B) TER was measured to assess culture integrity. C) Immunoblot analysis of autophagic, 
apoptotic and cilia markers. Molecular weights (kDa) are indicated to the right of the blots. 
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6.3 EMPHYSEMATOUS CHANGES AND APOPTOTIC MARKERS ARE 
ENHANCED IN AUTOPHAGY DEFICIENT HDAC6 MICE FOLLOWING 6 MONTHS 
OF CS EXPOSURE IN VIVO 
As observed in the MTEC cultures in vitro, the HDAC6-/Y mice were also predisposed to 
protein aggregate accumulation in vivo. Protein aggregates visualized with the ProteoStatTM 
protein aggregation dye were robustly induced by CS in HDAC6-/Y mice exposed to CS for 1 wk 
(Figure 13A). 
In order to more fully elucidate the role of HDAC6 in ameliorating CS induced stress in 
vivo, mice were exposed for 2 h/d to 150-200 mg/m3 CS 5 d/wk for 6 mo. The HDAC6-/Y mice 
displayed a comparable inability to gain weight as compared to the HDAC6+/Y mice, suggesting 
that the nicotine effects on metabolism are similar in these mouse strains (Figure 13B). In the 
HDAC6+/Y mice there was a 10% increase in mean chord length and in the HDAC6-/Y mice there 
was a 13% increase in mean chord length, a morphometric indices of emphysematous airspace 
enlargement (Figure 13C). While CS induced a statistically significant increase in airspace in 
both mouse strains, the airspace enlargement was not significantly different between the two 
strains treated with CS. Consistent with this observation there was a moderate enhancement of 
apoptotic markers in the HDAC6-/Y lung homogenates compared to CS exposed HDAC6+/Y 
(Figure 22D). Autophagic activity was assessed in the mice following 6 mo of CS exposure. 
Autophagic flux was significantly decreased in the HDAC6-/Y mice exposed to CS, while there 
was not a significant difference observed between the RA and CS wildtype mice (Figure 22E). 
These are the first data demonstrating that autophagy may play a cytoprotective function in 
epithelial cells exposed to CS, in which is efficient clearance of misfolded protein aggregates is a 
potential mechanism.  
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Figure 13. HDAC6-/Y mice are autophagy deficient and moderately more susceptible to CS induced 
injury. A) Airway cells containing numerous protein aggregate puncta (red; white arrows) in mice exposed 
to CS for 1 wk were visualized using ProteoStat™ and nuclei (blue) were stained with Hoechst. 
Representative images were acquired at 63X by confocal microscopy (bar = 10 μm). B-E) Mice were 
exposed to 150-200 mg/m3 CS for 2 h/d 5 d/wk for 6 months. All data are presented as the mean ± SE and 
statistical significance was determined by using a two-way ANOVA and Bonferroni post test. B) Mice 
were weighed following 6 mo of CS exposure. C) Emphysematous changes caused by CS exposure were 
assessed by morphometric assessment of chord lengths.  D) Apoptotic markers and HDAC6 protein 
expression was assessed in mouse lung homogenates. Molecular weights (kDa) are inidcated to the right of 
the blots. E) In vivo autophagic flux was assessed in the HDAC6+/Y and HDAC6-/Y mice following 6 mo of 
CS treatment. The mice were given an i.p. injection of 40 mg/kg leupeptin or vehicle within 3 h of the final 
smoke exposure and sacrificed in parallel 2 h later. Data are densiometric analyses using a GFP-LC3 
standard curve of LC3B accumulation in lysosome enriched protein fractions, determined by subtracting 
the average amount of LC3B present in the vehicle treated mice from the amount of LC3 accumulated in 
each of the leupeptin treated animals (n = 3-5 mice per group). 
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6.4 CILIA PROTEINS AS TARGETS OF CS-INDUCED AUTOPHAGIC 
DEGRADATION 
Since CS promotes misfolding of proteins, which are degraded by proteasomal or autophagic 
mechanisms, enhanced protein turnover would be most detrimental to dynamic structures 
requiring continual protein input, such as the motile cilia of the respiratory tract. In particular, 
cilia shortening is observed even in healthily smokers, suggesting either enhanced turnover over 
of cilia proteins or what may be more likely a lack of essential building blocks (88). In order to 
determine if cilia components are targets of autophagic degradation, cilia and autophagy markers 
were assessed following CS exposure in MTEC cultures. Immunofluoresence analysis suggested 
that 50 mg/m3 promoted LC3B localization to the cilia, while 100 mg/m3 was associated with 
accumulation of autophagosome puncta (Figure 14A). Since autophagic flux was most active 
following treatment with 50 mg/m3 CS TPM, these data indicate a CS-inducible association 
between this organelle and essential autophagy proteins in a context when autophagic flux is 
enhanced. In order to more fully determine if cilia components are actually encapsulated in 
autophagosomes to be degraded by autophagy following CS treatment, subcellular fractionation 
was performed to acquire a LE fraction (Figure 14B). The cilia marker centrin-1, which was 
decreased in MTEC cultures in which cilia were significantly diminished by CS treatment, was 
primarily localized to the cytoplasmic (Cyto) cell fraction in control cells. In the cells treated 
with 50 mg/m3 a faint centrin-1 positive band appeared in the LE fraction, in which selective 
autophagic flux was active. Centrin-1 was robustly relocalized to the LE fraction following 
treatment with 100 mg/m3 CS TPM, in which CS-induced flux inhibition would be expected to 
enhance the signal of autophagic targets. These data suggest that CS induces the autophagic 
degradation of cilia components following smoke exposure, and may promote the cilia loss and 
shortening that leave smokers’ lungs vulnerable to infections that promote COPD pathogenesis. 
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Figure 14. CS enhances the colocalization and 
subcellular fractionation of cilia and autophagy 
markers. A) Confocal analysis of MTEC culture z-
sections stained for nuclei (blue, Hoechst), 
autophagosomes (green, LC3B) and cilia (red, 
acetylated α-tubulin). (arrows-colocalization of 
LC3B and acetylated α-tubulin, arrow heads- cells 
filled with autophagosomes stained by LC3B. B) 
Immunoblot analysis of whole cell (WC), 
cytoplasmic (Cyto), and lysosome enriched fractions 
(LE) for cilia, autophagosome, and lysosome markers 
following  subcellular fractionation of MTEC 
cultures treated for 24 h with the indicated dose of 
CS (mg/m3 TPM). 
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7.0  RESULTS- THE FUNCTIONAL ROLE OF AUTOPHAGY PROTEINS IN THE 
RESPONSE OF EPITHELIAL CELLS TO CS: LC3B 
7.1 LC3B REGULATES CS-INDUCED AUTOPHAGY, APOPTOSIS, AND 
EMPHYSEMATOUS AIRSPACE ENLARGEMENT 
 
LC3B-/- mice were used to investigate the role of this autophagy protein in the response of 
epithelial cells to CS. MTEC cultures generated from LC3B-/- mice were exposed to 50 and 100 
mg/m3 CS TPM and assessed for autophagy and apoptotic markers (Figure 15A).  Consistent 
with previous findings LC3B promotes CS-induced cell death, as LC3B-/- MTEC cultures had 
less active cleaved caspase 3 and proapoptotic Bax cleavage fragment accumulation by 
immunoblot compared to MTEC cultures generated from wildtype mice (6). The enhanced 
accumulation of p62 SDS-insoluble protein aggregates in the LC3B-/- MTEC cultures is evidence 
that autophagic flux is defective in these mice. To further evaluate the role of LC3B in the 
cellular response to CS, emphysema development was evaluated in LC3B-/- mice, wildtype 
littermates (LC3B+/+), or C57BL/6 mice exposed to CS for 3 mo. Following this exposure, 
airspace enlargement, apoptosis, and autophagy markers were assessed in the lung. Consistent 
with previous observations, C57BL/6 wildtype mice displayed marked increases in lung airspace 
after 3 mo of CS exposure relative to RA controls as determined by comparative histological 
examination and mean linear intercept (Lm) measurements (Figure 15B) (294, 295). Similarly, 
LC3B+/+ wildtype littermate mice exposed to CS for 3 mo displayed marked increases in lung 
airspace after CS exposure relative to air-treated controls. In contrast, airspace was not increased 
in LC3B-/- mouse lungs by CS exposure relative to air-treated controls; however, the LC3B-/- 
mice exhibited significant basal airspace enlargement relative to wildtype littermate mice by Lm 
(Figure 15B). 
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 Airspace enlargement caused by CS exposure in LC3B-/- and wildtype mice was also 
assessed separately by measuring the equivalent diameter of alveolar airspaces using a 
previously published automated image processing algorithm (296). Consistent with the Lm 
measurements, the equivalent diameter of CS-exposed LC3B+/+ mice (31.5 ± 1.5 µm) was 
significantly greater than air-treated LC3B+/+ mice (27.9 ± 1.4 µm; p=0.001), whereas the 
equivalent diameter of CS-exposed LC3B-/- mice (30.7 ± 1.8 µm) was not different from the RA 
LC3B mice (29.0 ± 3.1 µm). The equivalent diameter of air-treated LC3B-/- mice was greater 
than that of the air-treated LC3B+/+ mice; however, the increase was not statistically significant.  
 To investigate lung cell death, apoptotic indices were measured, including cleaved 
caspase 9 and Bax/Bcl-2 ratio (Figure 15C). These markers were significantly increased in the 
lungs of the LC3B+/+ mice by CS exposure, but were not increased in the CS-exposed LC3B-/- 
mice. Furthermore, CS induced the accumulation of autophagic vacuoles (AVs) as determined by 
TEM, in the lungs of wildtype (LC3B+/+) mice (Figure 15D). In contrast, a reduced number of 
AVs were detected in the lung after CS exposure in the LC3B-/- mice. These data suggest that 
LC3B promotes CS-induced cell death both in vitro and in vivo.  
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Figure 15. LC3B regulates CS-induced autophagy and apoptosis in vitro and in vivo. A) MTEC 
cultures derived from wildtype C57BL/6 and LC3B-/- mice were assessed for autophagic and apoptotic 
markers 24 h after exposure to 50 or 100 mg/m3 CS TPM. B-E)  Wildtype C57BL/6, LC3B+/+ or LC3B-/- 
mice were exposed to chronic CS of RA for 3 mo (C57BL/6: n = 9 RA & n = 8 CS, LC3B+/+: n = 6 RA & n 
= 9 CS, LC3B-/- n = 9 RA & n = 9 CS). B) Quantification of MLIs (*P<0.01, by student’s unpaired t test) 
C) Densitometric analysis of immunoblots generated from lung protein samples for the apoptotic markers 
cleaved caspase 9 and the ratio of proapoptotic Bax to antiapoptotic Bcl-2. D) Representative TEM images 
of mouse lung sections. (Arrows: autophagic vacuoles; AVs) E) TEM images were scored for number of 
AVs. The data are represented as AVs per 100 μm2, n=20 representative images of each group; *p<0.05 by 
student’s unpaired t test. 
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7.2 LC3B INTERACTS WITH CAVEOLIN-1 AND FAS TO REGULATE CSE-
INDUCED AUTOPHAGY AND APOPTOTIC CELL DEATH 
To explore the mechanisms by which LC3B regulates CS-induced epithelial cell apoptosis, 
immunoprecipitation experiments were performed to identify apoptosis-related factors that 
interact with LC3B. In mammalian cells, the extrinsic apoptotic pathway responds to stimuli via 
activation of death receptor family proteins (297, 298). Stimulation with aqueous CS extract 
(CSE) induced the extrinsic apoptotic pathway in lung epithelial (Beas-2B) cells, involving 
death-inducing signaling complex (DISC) formation, caspase 8 activation, and Bax activation (8, 
60). We examined whether LC3B can interact with mediators of this pathway. LC3B interacted 
with Fas under basal conditions in Beas-2B cells whereas this interaction was rapidly disrupted 
after exposure to CSE (Figure 16A & B). Confocal imaging revealed that LC3B and Fas 
colocalized in the plasma membrane under basal conditions, whereas the merged complex of 
LC3B and Fas at the cell membrane was disrupted by CSE treatment (Figure 16B).  
Fas-mediated apoptosis involves the association of Fas with accessory molecules (i.e. 
procaspase 8, FADD). Recent studies show that Fas can localize to lipid rafts in the plasma 
membrane (60, 299). We therefore examined whether LC3B localizes to lipid rafts. Subcellular 
fractionation experiments demonstrated that LC3B and Fas also localized to low-density 
caveolin-1 (Cav-1) containing fractions under basal conditions in Beas-2B cells and lung 
fibroblasts (Figure 16C). Cav-1 serves as a structural component of caveolae, which are plasma 
membrane domains rich in cholesterol and glycosphingolipids. As Cav-1 interacts with several 
membrane-associated signaling proteins, the role of this protein in mediating the LC3B-Fas 
interaction at the plasma membrane was investigated (300). Cav-1, under basal conditions, 
interacted with both LC3B and Fas by co-immunoprecipitation assays (Figure 16D). 
Interestingly, both Cav-1-Fas and LC3B-Cav-1 complexes dissociated after CSE treatment. 
These data provide novel evidence for LC3B, Cav-1 and Fas interacting at lipid rafts in the 
plasma membrane, and the regulated disruption of this interaction by CS. 
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7.3 LC3B REGULATES FAS-MEDIATED APOPTOSIS IN CSE-TREATED BEAS-2B 
CELLS THROUGH INTERACTIONS WITH CAV-1 
In order to probe the effect of LC3B on Cav-1 interactions with Fas, Beas-2B cells were treated 
with LC3B siRNA. LC3B knockdown enhanced the basal interaction of Fas with Cav-1 (Figure 
17A). Furthermore, Beas-2B cells transfected with LC3B-siRNA exhibited reduced DISC 
formation and Bax activation in response to CSE relative to control siRNA treated cells (Figure 
17A).  
Figure 16. LC3B-Cav-1-Fas interactions regulate CSE-induced autophagy and apoptotic cell death. 
A) Representative immunofluorescence images of LC3B and Fas staining in Beas-2B cells. Colocalization 
is indicated by yellow staining in the merged images. B) Beas-2B cells were treated with 10% CSE for the 
indicated times and the interaction between LC3B and Fas was assessed by immunoprecipitation with 
LC3B and immunoblotting for Fas. β-actin served as the loading standard. C) Beas-2B  and wildtype 
fibroblasts were fractionated by sucrose gradient ultracentrifugation and the fractions were immunoblotted 
for Fas, LC3B and Cav-1. D) Beas-2B cells were expoed to 10% CSE for the indicated times and the 
lysates were subjected to immunoprecipitation with LC3B and Fas antibodies, and analyzed by immunoblot 
for Cav-1. β-actin served as the loading standard.  
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Proteins that bind Cav-1 typically contain a canonical Cav-1-binding motif (CBM), 
ФXФXXXXФ or ФXXXXФXXФ, where Ф is an aromatic amino acid and X is any 
nonaromatic amino acid. Proteins without such motifs are also capable of binding to Cav-1 
(301). The primary structure of LC3B contains a sequence, 108FLYMVYASQETF109 , which is a 
potential CBM. Amino acid substitution mutants of LC3B at position Y113 were created to 
examine whether this sequence mediates the LC3B-Cav-1 interaction. Interestingly, the Y113A 
mutation abolished the basal LC3B-Cav1 interaction (Figure 17B). Similar to observations made 
with LC3B-siRNA, transfection with the LC3B Y113A enhanced Cav-1-Fas interaction (Figure 
17B). Overexpression of wildtype LC3B in Beas-2B cells markedly augmented cell death in 
response to CSE treatment. By comparison, overexpression of LC3B Y113A also induced cell 
death, although to a lesser degree than the WT LC3B construct (Figure 17C). These experiments 
suggest that LC3B promotes CSE-induced cell death in part through a mechanism dependent on 
the Cav-1-binding motif.  
To further explore the mechanism by which Cav-1 facilitates Fas and LC3B interaction, 
we confirmed that LC3B binding to Cav-1 was dependent upon the Cav-1 scaffolding domain 
(CSD), which mediates interactions with the CBMs of other proteins. The interaction between 
LC3B and Cav-1 was assessed by co-immunoprecipitation following transfection of Beas-2B 
cells with either wildtype Cav-1 or Cav-1 cells bearing a mutated CSD (ΔCSD) (Figure 17D). 
Cells transfected with the Cav-1 ΔCSD showed decreased interaction between LC3B and Cav-1 
compared to cells transfected with WT Cav-1. Fas binding was not affected by the ΔCSD 
mutation. These data confirm the importance of the LC3B CBM and Cav-1 CSD domains for 
mediating the interaction between these two proteins. While Fas expression was slightly 
increased in Cav-1-/- lung fibroblasts, the LC3B Fas interaction was diminished, suggesting an 
intermediate role for Cav-1 in complex formation (Figure 17E).  
Since Fas-Cav-1 binding was not affected by expression of the ΔCSD mutation, 
additional sites of interaction were explored. Cav-1 has three sites of palmitoylation in proximity 
to the C-terminus. The Cav-1-Fas interaction was disrupted in Beas-2B cells treated with 2-
bromopalmitate, a general palmitoylation inhibitor (Figure 17F). Fas is also palmitoylated on 
cysteine 199, this modification was required for mediating the Fas-Cav-1 interaction, as 
transfection with mutant Fas C199S abolished the interaction (Figure 17G). Surprisingly, Fas 
siRNA diminished the Cav-1-LC3B interaction. Cav-1 appears to mediate the interaction 
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between Fas and LC3B; however, Fas promotes LC3B binding to Cav-1, while LC3B hinders 
Fas binding to Cav-1. These data suggest a complicated interdependence of all three factors in 
complex formation and suggest that loss of LC3B may enhance survival by increasing the Fas 
Cav-1 interaction (Figure 17H).  
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Figure 17. Mapping the LC3B-Cav-1-Fas interaction. A) Beas-2B cells were pretreated with control siRNA (C-
siRNA) or LC3B siRNA for 48 h and then treated with 10% CSE for the indicated times. The lysates were then 
subjected to the indicated immunopercipitation and immunoblot analysis. B) Beas-2B cells were transfected with 
wildtype LC3B or Y113A LC3B for 48 h and the interaction between LC2B-Cav-1-Fas was then assessed by 
immunopercipitation and immunoblot analysis. C) Beas-2B cells were transfected with vector, wildtype LC3B, or 
Y113A LC3B for 48 h and viability was then assessed by MTT assay after treating the cells with the indicated 
concentration of CSE for an additional 24 h.  Data represent mean ± SD; *p<0.05 vs corresponding vector control 
values; #P<0.05 vs corresponding values for wildtype-LC3B overexpression. D) Wildtype Cav-1 and ΔCSD Cav-1 
expression clones were transfected into Beas-2B cells for 36 h and then the cells were exposed to 10% CSE for 1 h. 
The LC3B-Cav-1-Fas interaction was then assessed by immunopercipitation and immunoblot. The data are 
representative of three independent experiments. E) Cell lysates from wildtype or Cav- -/- fibroblasts treated with 
10% CSE for the indicated times were subjected to immunopercipitation for LC3B and immunoblot of Fas. A 
nonspecific IgG band served as the standard. Cav-1 and Fas expression was assessed by immunoblot in the wildtype 
and Cav-1-/- fibroblasts. F) Beas-2B cells were treated with 100 μM 2-bromopalmitate (2-Br), a general 
palmitoylation inhibitor, or DMSO for one hour and subjected to coimmunoprecipitation assays for Cav-1-Fas 
interaction (left). Beas-2B  cells were transfected for 36 h with wildtype Fas and C199S  Fas. The cells were 
exposed to 10% CSE for 1 h and subjected to immunoprecipitation and immunoblot analysis for Fas-Cav-1 
interaction (Right). Representative immunoblot data from three independent experiments. G)  Beas-2B cells were 
pretreated with CTL siRNA or Fas siRNA for 48 h, followed by exposure to 10% CSE for the indicated times. The 
lysates were subjected to immunoprecipitation and immunoblot analysis. H) A schematic of the proposed LC3B-
Cav-1-Fas complex, in which the Fas interaction with Cav-1 is dependent upon Fas palmityolation at cystein 199, 
while LC3B interacts through the Cav-1 scaffold domain (CSD). 
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7.4 LC3B INTERACTING PROTEIN, CAV-1, SUPPRESSES CSE-INDUCED 
AUTOPHAGY AND APOPTOTIC CELL DEATH IN BEAS-2B CELLS  
The role of Cav-1 in pulmonary disease remains controversial, since Cav-1 has been shown to 
play protective and deleterious functions in various models of lung disease (302-306). 
Furthermore, the role of Cav-1 in COPD pathogenesis remains poorly understood. Cav-1 appears 
to regulate CS-induced autophagy and cell death. In order to more fully elucidate the role of 
Cav-1 in this these processes, Beas-2B cells were transfected with Cav-1 siRNA and treated with 
CSE to determine the effects on autophagic and apoptotic markers (Figure 18). Cav-1 siRNA 
enhanced the accumulation of AVs observed in Beas-2B cells basally and following CSE 
treatment (Figure 18A). Autophagosome accumulation was also apparent in Cav1-siRNA 
treated cells by LC3B II immunoblot (Figure 18B). Cav-1 siRNA also enhanced CSE induced 
markers of cell death including cleaved caspase 3 and PARP cleavage in Beas-2B cells (Figure 
18C). Consistent with induction of apoptotic markers, cell viability in response to increasing 
concentrations of CSE was significantly decreased in Cav-1 siRNA treated cells compared to 
controls (Figure 18D). These data suggest that Cav-1 is an important negative regulator of both 
autophagy and apoptosis. 
Figure 18. Cav-1 suppresses CSE-induced autophagy and apoptotic cell death in vitro. A-D) Cells were 
transfected with siRNA for 48 h and treated with the indicated concentrations of CSE for 24 h. A) AVs were 
quantified by TEM. The data are represented as AVs per 100 μm2 with n=20 representative images for each 
group. Data are presented as mean ± SD; *p < 0.05 by student’s unpaired t test. B) Immunoblot analysis of LC3B 
and Cav-1 following siRNA treatment. Β-actin was the loading standard. C) Apoptotic markers were assessed in 
Beas-2B cells treated with Cav-1 siRNA following CSE exposure. D) The effects of Cav-1 knockdown on cell 
viability was determined by MTT assay following treatment with the indicated concentrations of CSE.  
 
 62 
7.5 LC3B INTERACTING PROTEIN, CAV-1, REGULATES CS-INDUCED 
AUTOPHAGY AND APOPTOSIS IN VIVO  
To further elucidate the role of Cav-1 in mediating cellular responses to CS, Cav-1-/- and 
wildtype mice were exposed to CS for 3 mo. Consistent with the in vitro findings, CS-exposed 
Cav1-/- mice exhibited significantly higher levels autophagic vacuole accumulation by TEM and 
LC3B II immunoblot (Figure 19 A & B). Cav-1-/- mice also exhibited significantly higher levels 
of apoptosis, as evidenced by activation of caspase 9 in the lungs following CS exposure (Figure 
19C). Although the Cav-1-/- mice had basal lung airspace enlargement, they were more 
susceptible to CS-induced lung injury and displayed a further enlargement of airspace (Figure 
19D). These data indicate that Cav-1 is a critical regulator of CS-induced autophagy and 
apoptosis in vivo. 
Figure 19. Cav-1 regulates CS-induced autophagy and apoptosis in vivo. A-D) Wildtype C57BL/6 or Cav-1-/- 
mice were exposed to CS for 3 mo (n = 5 for each group). A) AVs were quantified per area from 20 representative 
TEM images for each group. B) Densiometric analysis of immunoblots quantifying the LC3BII/LC3BI ratio in 
mouse lung tissue. C) Apoptotic marker, cleaved caspase 9, quantification by immunoblot densitometry from mouse 
lung tissue samples. D) MLI morphometric analysis of airspace enlargement in mouse lungs. Data represented as 
mean ± SD; *p < 0.05 by student’s unpaired t test. 
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8.0  RESULTS- THE FUNCTIONAL ROLE OF AUTOPHAGY PROTEINS IN THE 
RESPONSE OF EPITHELIAL CELLS TO CS: BECLIN-1 
8.1 BECLIN-1 PROMOTES CS-INDUCED DISRUPTION OF INTERCELLULAR 
INTERACTIONS AND CILIATED CELL LOSS 
To better understand the role of autophagy in the response of airway epithelial cells to CS, 
MTEC cultures were generated from Beclin-1+/- mice. Morphological changes were assessed by 
fluorescence microscopy using F-actin and acetylated α-tubulin as markers. While the cells 
appeared morphologically similar following treatment with 50 mg/m3, Beclin-1+/+ cells treated 
with 100 mg/m3 showed marked disruption of intercellular contacts and cilia compared to the 
Beclin-1+/- cells (Figure 20A). SEM confirmed the immunofluorescence observations, in which 
the untreated control cells appear grossly similar in the Beclin-1+/+ and Beclin-1+/-, suggesting 
that Beclin-1 does not play a critical role in epithelium and/or cilia formation and maintenance. 
There was clear protection of the epithelial cell layer in the Beclin-1+/- treated with 100 mg/m3 
(Figure 20B). In addition, there was a significantly higher percentage of ciliated cells that 
survive following 100 mg/m3 CS exposure in the Beclin-1+/- MTEC cultures (Figure 20C). Since 
autophagic flux was acutely inhibited following CS treatment with 100 mg/m3 in MTEC 
cultures, these data suggest that Beclin-1+/- cells may be protected from CS-induced injury by a 
mechanism independent of autophagic degradation.  
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Figure 20. MTECs derived from Beclin-1+/- mice are protected from CS-induced injury. A) Disruption 
of intercelluar contacts and cilia was monitored by epifluoresence imaging of cells stained for nuclei (blue; 
Hoescht 33258), cytoskeletal F-actin (green, phalloidin conjugated to Alexa-488), and cilia (red, acetylated 
α-tubulin). Images were acquired at 100X in the same field at different focal planes. B) Scanning electron 
microscopy was implemented to directly visualize the apical surface of the epithelial layer following 
treatment with 50 and 100 mg/m3 TPM (bar=10um). C) The percentage of ciliated cells in the Beclin-1+/+ 
and Beclin-1+/- was determined by quantifying ciliated cells to total nuclei in 5-10 random fields from 4 
independent experiments. Statistical significance was determined by two-way ANOVA *p<0.05 
 
Beclin-1+/+ Beclin-1+/- 
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8.2 BECLIN-1 PROMOTES CS-INDUCED AUTOPHAGOSOME ACCUMULATION 
TEM was implemented to assess the cellular morphology and autophagic response of Beclin-1+/- 
compared to Beclin-1+/+ MTEC cultures. Representative TEM images demonstrate that overall 
cellular morphology and cilia formation was similar in the cultures (Figure 21A). From these 
analyses double membrane autophagosomes containing lipid material reminiscent of lamellar 
bodies was observed in both types of cultures basally. In the Beclin-1+/+ cells 50 mg/m3 CS TPM 
treatment caused an accumulation of large aggregates composed primarily of these lamellar 
bodies. As previously demonstrated, 100 mg/m3 caused cell death associated with autophagic 
vacuole accumulation and loss of ciliary axonemes in the Beclin-1+/+ MTEC cultures (Figure 8A 
& Figure 21A). In contrast, the Beclin-1+/- MTEC cultures were resistant to cell death and were 
not characterized by an accumulation of numerous cytoplasmic vacuoles or cilia loss. 
Quantitative analysis of the TEM images indicated that autophagosomes were equally prevalent 
in the Beclin-1+/+ and Beclin-1+/- cultures in control conditions, suggesting that basal formation 
of autophagosomes is not significantly altered by heterozygous deletion of this critical autophagy 
protein (Figure 21B). However, CS-induced accumulation of autophagosomes is reduced in the 
Beclin-1+/- cultures following treatment with 50 mg/m3 CS TPM. These data confirm that Beclin-
1 is not critical for epithelial cell morphology or cilia formation. While basal autophagosome 
formation was similar in both Beclin-1+/+ and Beclin-1+/- cultures, there is repression of 
autophagosome accumulation in the Beclin-1+/- cells following CS exposure.  
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Figure 21. Beclin-1+/- MTEC ciliated cells are resistant to CS induced autophagosome 
accumulation. A) Representative TEM images of MTEC cultures 24 h after exposure to the indicated 
concentration of CS (red arrows-autophagosomes, black double arrows- large aggregation of lipid-based 
materials, a-axoneme, bb-basal bodies, m-mitochondria, n-nucleus, Bar = 500 nm).  B) Autophagosomes 
were quantified in cells exposed to RA or 50 mg/m3 CS TPM from 20 images acquired at 6500X. Data 
are presented as the mean number of autophagosomes per unit area ± SE. Statistical significance *p<0.05 
was determined by two-way ANOVA and Bonferroni post test. 
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8.3 BECLIN-1 PROMOTES CS-INDUCED CELL DEATH 
To further characterize and confirm the nature of Beclin-1+/- MTEC culture protection from CS-
induced injury, the resistance was measured 24 h after exposure to 50 and 100 mg/m3 CS TPM. 
Consistent with the imaging data the integrity of the epithelial layer was significantly protected 
in the Beclin-1+/- MTEC cultures (Figure 22A). CS-induced cytotoxicity was determined by 
measuring LDH in the basal media (Figure 22B). There was significantly less LDH activity, 
suggesting that the Beclin-1+/- MTEC are resistant to CS induced cell death. Immunoblot analysis 
of protein samples generated from the cultures treated with 50 and 100 mg/m3 CS TPM and 
harvested 24 h later was used to assess autophagic, apoptotic, oxidative and cilia markers 
(Figure 22C). Active, cleaved caspase 3 was not detected in any of the Beclin-1+/- cultures 
treated with CS, while 100 mg/m3 induced caspase 3 cleavage in the wildtype cells, thereby 
corroborating the findings of the LDH assay. The autophagic marker p62 demonstrated the usual 
SDS-insoluble high molecular weight aggregate in the wildtype culture treated with 100 mg/m3. 
Surprisingly these high molecular weight bands, which usually indicate inhibited autophagic 
flux, were not enhanced in the Beclin-1+/- cultures. Beclin-1 protein expression was moderately 
reduced in Beclin-1+/- cultures; however, the appearance of a Beclin-1 reactive band at ~35 kDa 
in highly apoptotic Beclin-1+/+ cultures is noteworthy. A C-terminal fragment of Beclin-1 at this 
molecular weight was previously implicated as serving a proapoptotic function at the 
mitochondrial membrane (138, 268-270, 307). Since Beclin-1 is a BH3-only domain containing 
protein that interacts with Bcl-2, reduced levels of Beclin-1 protein may alter and potentially 
enhance the antiapoptotic role of Bcl-2 in the CS exposed cells (308, 309). Consistent with this 
postulation, in cultures treated with 100 mg/m3 CS TPM Bcl-2 protein expression is decreased in 
Beclin-1+/+ cultures, while this protein is increased in the Beclin-1+/- cultures. Finally, autophagy 
regulates the antioxidant Nrf-2 pathway, and many studies have noted enhanced antioxidant 
capacity with autophagy deficiency (224, 310). In support of these prior findings, Nrf-2 appears 
to be slightly upregulated in the Beclin-1+/- MTEC cultures. Finally, consistent with 
quantification of ciliated cells, the basal body protein centrin-1 expression is decreased in the 
highly apoptotic Beclin-1+/+ cultures, while the protein steady-state protein expression is not 
altered in the Beclin-1+/- cultures. These analyses suggest that the Beclin-1+/- MTEC cultures are 
protected from CS-induced injury at many levels and may employ a number of molecular 
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mechanisms both dependent and independent of autophagic activity to exert this protective 
effect.  
 
 
Figure 22. MTECs derived from Beclin-1+/- mice are protected from CS-induced cell death. A) TER, a 
measure of culture integrity, was measured 24 h following CS treatment with 50 and 100 mg/m3 TPM. 
**p<0.001 by two-way ANOVA with Bonferroni post test  B) Cytotoxicity was measured by assaying 
LDH in the basal media 24 h after CS exposure. Quantities are in arbitrary units (AU). Statistical 
significance ***p<0.001 was determined by two-way ANOVA and Bonferroni post test. C) Representative 
immunoblot analysis of autophagic, apoptotic, oxidative stress, and cilia markers in MTEC cultures 24 h  
after CS treatment. Apparent molecular weights (kDa) are indicated to the right of the blots. 
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8.4 BECLIN-1+/- MICE EXPOSED TO CS FOR 6 MONTHS ARE AUTOPHAGY 
DEFICIENT AND RESISTANT TO EMPHYSEMATOUS CHANGES 
To further elucidate the role of Beclin-1 in the response of epithelial cells to CS, Beclin-1 +/+ and 
+/- mice were exposed to CS for 6 mo in vivo. Since mouse strains susceptible to emphysematous 
changes show a significant difference in weights between RA and CS mice, the mice in all four 
groups were weighed at the end of the 6 mo exposure (Figure 23A). While there was a 
statistically significant difference in weights between RA and CS mice, there was not a 
significant difference between the Beclin-1 wildtype and heterozygous mice. These data indicate 
that the neuroendocrine and metabolic effects of nicotine on the mice are not significantly altered 
in the Beclin-1+/- strain. Since the purpose of using Beclin-1+/- mice is to have a defect in 
autophagy, autophagic flux was assessed in these mice in vivo (Figure 23B). Similar to the prior 
MTEC findings, Beclin-1+/- flux was significantly reduced in the CS treated mice, while basal 
flux in the RA mice was similar to the wildtype controls (Figure 23B). At this time point there 
was no longer a significant difference in autophagic activity in the wildtype RA and 6 month CS 
exposed mice, in contrast to the prior flux analysis of the 1 wk and 2 mo CS exposed mice 
(Figure 10B). The flux of the smoked mice was not altered significantly between these 
experiments, but the RA mice have more autophagic activity in the 6 mo CS experiment. 
Previous in vitro studies have proposed a model in which cells show greater reliance on 
autophagic degradation over the UPS with senescence (175, 179).  
Consistent with the findings that Beclin-1+/- cultures were protected from CS-induced 
injury, Beclin-1+/- mice were resistant to CS-induced emphysematous changes (Figure 23C). 
While the wildtype littermates had a 13% increase in airspace caused by CS the airspace of the 
Beclin-1+/- CS exposed mice increased less than 1% compared to the RA controls. Finally, 
immunoblot analysis of apoptotic indices was used to assess cell death in lung protein 
homogenates. The expression pattern of Bcl-2 in tissue exactly recapitulated the in vitro findings, 
in which Bcl-2 expression decreases with smoke treatment in wildtype mice and increases in the 
heterozygous mice (Figure 23C). Finally, PARP cleavage fragments were more abundant in the 
Beclin-1+/+ compared to the Beclin-1+/- lungs following CS exposure. These data confirm that 
there is defective autophagy in Beclin-1+/- mice and that this protein plays a critical role in 
mediating CS-induced injury.   
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Figure 23. Assessment of injury in Beclin-1+/- mice exposed to CS for 6 months. A) Beclin-1+/+ and 
Beclin-1+/- mice were weighed following 6 mo of CS exposure along with RA controls. Data are presented 
as the mean ± SE and statistical significance was determined by two-way ANOVA with Bonferroni post 
tests (***p < 0.001) B) In vivo autophagic flux was assessed in the Beclin-1+/+ and Beclin-1+/- mice 
following 6 mo of CS treatment. The mice were given an i.p. injection of 40 mg/kg leupeptin or vehicle 
within 3 ho of the final smoke exposure and sacrificed in parallel 2 h later. Data are presented as 
densitometric analyses using a GFP-LC3 standard curve of LC3B accumulation in lysosome enriched 
protein fractions, determined by subtracting the average amount of LC3B present in the vehicle treated 
mice from the amount of LC3 accumulated in each of the leupeptin treated animals (n=3-5 mice per group). 
Data are presented as the mean ± SE and statistical significance was determined by using a two-way 
ANOVA and Bonferroni post test. C) Emphysematous changes were assessed by measuring airspace chord 
lengths. A chord length value for each mouse was determined by analyzing 5-10 randomly selected 20X 
fields. The data are presented as the mean ± SE and statistical significance was determined by two-way 
ANOVA with Bonferroni post test. D) Immunoblot analysis of apoptotic indices in mouse lung tissue. 
Representative data of n=3 mice for each treatment group. Apparent molecular weights (kDa) are indicated 
to the right of the blots. 
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9.0  DISCUSSSION 
The purpose of this study was to elucidate the functional significance of autophagy in lung 
epithelial cells exposed to CS, to gain insights into COPD pathogenesis. A physiologically 
relevant model of the airways, MTEC cultures grown at an ALI, was developed to assess the 
contribution of autophagy in the morphological alterations observed in the epithelium following 
CS exposure. Since little is known about autophagic activity in the lung, autophagic flux was 
first assessed following acute and chronic CS exposure in vitro using the MTEC cultures, as well 
as in vivo. In order to explore the importance of CS in determining the targets of autophagic 
degradation, HDAC6, which was previously implicated in clearance of misfolded aggregates and 
cilia regulation, was also investigated. As cilia undergo remodeling in response to CS exposure, 
the colocalization of cilia and autophagic markers was investigated to determine whether cilia 
components might be targets of autophagic degradation. Finally regulation and function of 
autophagy in CS-induced cell death was assessed, with particular focus on the autophagy 
proteins of LC3B and Beclin-1. By probing autophagic activity, autophagic substrates, and the 
functions of multiple autophagy proteins in mediating the cellular response to CS, a more 
comprehensive understanding of the autophagic process in the lung is emerging that may provide 
important insights into CS-induced cell death and COPD pathogenesis.  
9.1 MTEC CULTURES AS A PHYSIOLOGICAL MODEL OF CS EXPOSURE IN 
VITRO 
In this study a physiologically relevant in vitro model was developed of CS exposure, which 
recapitulated the intercellular junction remodeling, cilia injury/loss, autophagosome 
accumulation and cell death observed in vivo (Figures 4-7). Unlike cells grown using standard 
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submerged cultures, the MTEC cultures are highly differentiated and can be treated with 
mainstream whole smoke, mimicking the in vivo milieu. The purity of the epithelial cell 
population allows for a clearer interpretation of the significance of these cells in the response to 
CS, without contamination from cells of parenchymal, endothelial, or mesenchymal origin. Since 
immune cells are excluded from the cultures, this system allows for direct determination of 
epithelial cell involvement in the CS-induced inflammatory cascade. The cultures are also 
amenable for distinguishing between apical, and basolateral mediator release, imaging analysis 
and acquisition of protein samples. Furthermore, the use of mouse-derived cells allows for direct 
comparisons between transgenic and knockout strains.  While this model system is labor 
intensive, produces a low cell yield, and requires 4 wk to fully differentiate before 
experimentation, this model is more relevant than previous models using CSE and the only in 
vitro model in which the effects of CS can be determined on a specific cell type in the airways, 
as transformed lung-derived cell lines are not well differentiated. 
9.2 REGULATION OF AUTOPHAGIC FLUX BY CS 
As described previously, flux is generally assessed by comparing the turnover of a protein (i.e. 
p62 or LC3B) specifically targeted for autophagic degradation in control and treated cells. This 
assay requires four treatment groups, control and treated cells without an inhibitor of 
autophagolysosome degradation and control and treated cells with an inhibitor of 
autophagolysosome degradation. The difference between the basal and inhibitor treated cells 
indicates the autophagic flux for that particular treatment. The greater the difference between the 
basal and autophagic inhibitor treated cells, the more autophagic flux. 
9.2.1 Effects of CS on autophagic flux in vitro 
Previous studies have demonstrated that CS induces autophagosome accumulation, imlying that 
CS has a direct effect on the autophagic process. In this study, CS-induced autophagosome 
accumulation was assessed in MTEC cultures treated acutely with CS to confirm these prior 
findings (Figure 8). In order to more fully elucidate the regulation of autophagy in this model, 
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autophagic flux was also assessed in MTEC cultures following acute and chronic CS treatments 
(Figure 9).  
LC3B turnover was not significantly induced by CS treatment in any of the MTEC 
cultures, reflecting the high catabolic status of the control cells (Figure 9). This finding is 
consistent with previous observations that confluent, quiescent cells generally have higher rates 
of basal autophagic activity than proliferating cells in vitro. Selective autophagy mediated by p62 
was found to be increased by 50 mg/m3 CS TPM following both acute and chronic exposure 
regimens (Figure 9). CS-induced transcriptional upregulation of p62 may contribute to the 
observed increase in turnover, as this protein is regulated by an Nrf-2 antioxidant response 
element (188). These data indicate that low doses of CS induce selective autophagy in MTEC 
cultures. 
9.2.2 Effects of CS on autophagic flux in vivo 
In this study autophagic activity was assessed in mice exposed to CS. A time dependent 
induction of autophagic activity as measured by LC3B turnover in mice exposed to CS for 1 wk 
and 2 mo, which was sustained 24h following CS exposure, was observed (Figure 10). These 
data indicate that CS may have a prolonged effect in the lung that persists even after the initial 
insult is removed. In addition, the time dependent induction of autophagic activity from 1 wk to 
2 mo, suggests that there may be positive feedback loops enhancing the autophagic response 
with continued stimulus. In contrast to the findings of mice treated for 1 wk and 2 mo, 
autophagic flux was no longer significantly upregulated in wildtype mice exposed to 6 m of CS 
compare to RA controls (Figure 13E & 23B). These are the first in vivo flux assays to 
demonstrate the effects of CS on autophagy in the lung, and these data suggest an important 
dependence between autophagic activity and duration of CS exposure. 
9.3 HDAC6 MEDIATES CLEARANCE OF MISFOLDED PROTEINS IN THE LUNG 
Consistent with the finding that chronic smoke exposure may lead to an attenuation or 
dysregulation of autophagy, protein aggregate accumulation in the airways and parenchyma of 
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patient tissues appeared to correlate with COPD severity (Figure 11A). Furthermore, HDAC6, a 
protein implicated in the efficient clearance of misfolded protein aggregates and mediating 
autophagosome-lysosome fusion, is upregulated as a fundamental physiological response to CS 
in lung tissues from patients (Figure 11B). These human data corroborate the recent findings in 
which UPR activation and ubiquitin aggregate accumulation demonstrated a positive correlation 
with severity of emphysema (237). The deleterious effects of misfolded proteins have been 
described in numerous organ systems, such as the brain and liver, which are now being 
elucidated in the lung (237, 242, 311). The importance of protein folding stress in the lung has 
been demonstrated in a number of studies. For example, mutations leading to aggregation of SP-
C have been implicated in interstitial lung disease and misfolded proteins also accumulate in the 
lung in models of sepsis and acute lung injury (311-313). However, little is known about the 
contribution of CS-induced protein aggregates in the pathogenesis of COPD. Since degradation 
of these protein aggregates is primarily mediated by autophagy, significant insights may be 
gained by studying the contribution of CS, misfolded protein aggregates and autophagy in COPD 
pathogenesis.  
In this study CS was found to induce the accumulation of misfolded proteins aggregates 
in MTEC cultures in vitro and in vivo (Figure 12A & 13A). Consistent with the hypothesis that 
HDAC6 plays a role in CS-induced protein aggregate clearance, HDAC6-/Y cells and lungs 
appeared to have increased numbers of misfolded protein aggregates, which was further 
augmented by CS (Figure 12A & 13A). These data are consistent with prior findings, in which 
HDAC6 was previously implicated in the aggregation of mutant CFTR near the microtubule 
organizing center and protection of A549 cells from the toxic effects of expressing this misfolded 
protein (198). HDAC6 deacetylase activity has been previously show to be sufficient to confer 
protection from protein aggregation and UPS inhibition in drosophila, and to promote 
autophagosome-lysosome fusion through deacetylation of cortactin (194, 207). The findings of 
this study and those of prior studies suggest that HDAC6 may be an integral mediator of the 
autophagic clearance of misfolded proteins, particularly those produced by CS exposure.  
The accumulation of misfolded proteins in untreated MTEC cultures suggests that 
HDAC6 is critical for removing these aggregates even in the basal state. The high levels of basal 
apoptosis observed in the HDAC6-/Y cultures, supports the importance of this protein in cellular 
homeostasis (Figure 12C). Cell death assessed by cleaved caspase 3 was enhanced further by 
 75 
treatment with 50 mg/m3 cells. Surprisingly, this stress did not potentiate CS-induced cell death, 
which was mitigated relative to the wildtype cells treated with 100 mg/m3 CS TPM (Figure 
12C). HDAC6 is a complex protein with many targets; therefore, these data suggest that this 
protein may have a dual role, promoting homeostasis in basal conditions and cell death under 
stress, or that loss of this protein induces compensatory mechanisms that mitigate CS-induced 
stress.  
9.4 CS-INDUCED AUTOPHAGY AND CILIATED CELL INJURY 
CS-induced challenges to protein folding and enhanced protein degradation may also contribute 
to cilia shortening and loss observed in smokers. Cilia are dynamic organelles with continuous 
protein input and turnover, which is mediated by ubiquitination of ciliary proteins in the cilium 
and degradation in the cytoplasm (94). The in vitro data from this study indicate that there are at 
least two mechanisms promoting cilia/ciliated cell loss by smoking: 1) desquamation with loss of 
intercellular contacts and 2) cilia shortening/scarcity with maintenance of intercellular integrity 
(Figure 5).  
 Cilia shortening was observed in MTEC cultures treated with 50 mg/m3 CS TPM. By 
SEM these cells had fewer or shorter cilia per cell and maintained intercellular contacts. At this 
dose of CS there was also an increase in the colocalization of LC3B and acetylated α-tubulin in 
the cilia implicating autophagy in cilia turnover during CS exposure (Figure 5B & 14A). 
In these studies desquamation, in which ciliated cells succumbed to cell death and shed 
out of the epithelium, may disrupt apical-basal polarity cues leading to significant morphological 
changes in the remaining viable epithelial cells (Figure 5). Previous studies demonstrated that 
proportions of shed ciliated cells directly correlated with ciliary dynein, suggesting that CS does 
not induce significant axoneme shedding (87). Since cell death is a major contributing factor for 
this mechanism of CS-induced ciliated cell loss, cell vulnerability to cell death plays a major role 
in the observed cilia phenotype. The basal body marker of cilia, centrin-1, was significantly 
decreased in cells treated with 100 mg/m3 CS TPM; however, this cilia marker was protected in 
HDAC6-/Y and Beclin-1+/- cells, which were resistant to CS-induced cell death (Figure 12C & 
22C).  
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At both doses, 50 and 100 mg/m3 CS TPM, centrin-1 was recovered in the LE fraction 
(Figure 14B). The signal was particularly strong in the cells treated with 100 mg/m3, in which 
ciliated cell death occurred with complete loss of ciliary axonemes, as well as, decreased 
autophagic flux, which would augment the signal of proteins targeted for autophagic turnover. 
These data suggest that autophagy and autophagy associated proteins may exert effects on the 
ciliated cells of the respiratory epithelium at two points, by mediating CS-induced cell death and 
direct degradation of cilia proteins.      
9.5 AUTOPHAGIC FLUX IN CS-INDUCED CELL DEATH 
To assess the role of autophagic activity in CS-induced cell death, MTEC cultures were treated 
with 100 mg/m3 rapidly, which rapidly induced apoptosis (Figure 6). Time dependent induction 
of autophagic and apoptotic markers were observed following this lethal CS treatment. There 
was an acute accumulation of LC3B II, which proceeded the generation of cleaved caspase 3 
(Figure 8D). Similarly, there was an accumulation of p62 SDS-insoluble high molecular weight 
aggregates, which is generally interpreted a marker of impaired autophagic activity (Figure 8D). 
By TEM, cells filled with autophagic vacuoles undergoing apoptosis were observed 24 h after 
CS exposure (Figure 8A). Upon assaying for flux in these cells we determined that autophagic 
activity is acutely inhibited by this treatment in an ATP-independent manner (Figure 9A & 9B). 
Based on the observation that LC3B and p62 levels are slightly decreased after 6 h of CQ, 
despite inhibition of flux, these data suggest that global transcriptional downregulation may be 
the primary mechanism by which flux is acutely inhibited in this model (Figure 9A).  
In the chronic MTEC model, in which cells were treated for up to 3 d with 50 mg/m3 CS 
TPM, cell death was also induced following the final 24 h exposure. In contrast to the acute 
model, selective autophagic flux was upregulated in these cells. (Figure 7 & Figure 9C). Since 
the flux assay was conducted in the first three hours after CS treatment and apoptosis was 
evident at 24 h, autophagic activity upon execution of cell death was not determined in this 
model. 
These data demonstrate the importance of CS dose on the autophagic response. While 
flux is inhibited in the acute model, possibly via stress induced global inhibition of protein 
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synthesis, chronic CS exposure may prime cells for cell death associated with increased 
autophagic activity.  
9.6 AUTOPHAGIC PROTEINS MEDIATE CROSSTALK TO APOPTOSIS 
9.6.1 LC3B promotes CS-induced extrinsic apoptosis 
The results of the in vitro CSE experiments suggest that LC3B plays a regulatory role in extrinsic 
apoptosis activation, through a dynamic interaction with Fas mediated by Cav-1. These results 
are consistent with our previous observations that siRNA knockdown of LC3B conferred 
protection, while LC3B overexpression promoted epithelial cell apoptosis induced by CSE (6). 
The interaction of LC3B and Fas was facilitated by Cav-1 and acutely disrupted by CSE 
treatment. The requirement for Cav-1 in LC3B/Fas interaction, as well as reciprocal complex 
formation between Cav-1 and LC3B or Fas, suggests the formation of a multiprotein complex 
composed of all three proteins. While Fas and LC3B bound to Cav-1 via different sites, the data 
support allosteric regulation, in which LC3B levels negatively correlate with Fas sequestration 
by Cav-1. 
Mutation of the Cav-1-binding site in LC3B (Y113A) resulted in loss of LC3B/Cav-1 
interaction in vitro. Transfection of LC3B Y113A resulted in reduced apoptosis in response to 
CS relative to wildtype LC3B. These results indicate that the interaction of LC3B with Cav-1 is 
required for the proapoptotic function of LC3B in this model. The reduced effectiveness of 
LC3B Y113A relative to wildtype LC3B at promoting apoptosis may be a result of the apparent 
increase in the Cav-1/Fas interaction, which consequently reduces the activation of the extrinsic 
apoptotic pathway (Figure 17B & 17C). The dissociation of LC3B and Fas from Cav-1 is 
stimulated by CSE, which permits further progression of the extrinsic apoptotic pathway. The 
elucidation of the molecular mechanism(s) for the dissociation of these regulatory complexes by 
pro-death stimuli requires further investigation.   
The studies also suggest that Cav-1 can exert a functional role in CS-induced emphysema 
development by downregulating autophagic and apoptotic pathways. This observation appears to 
be a general mechanism, since Cav-1 has been implicated in the sequestration and inactivation of 
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a diverse group of signaling molecules at caveolae, including Src, Ras, epidermal growth factor 
receptor (EGFR), and platelet derived growth factor (PDGF) (314). In the current study, we 
show that Cav-1-/- mice are more susceptible to CS-induced cell death and AV accumulation in 
lung tissue. In agreement with our current findings, a recent study has also demonstrated 
increased autophagy in several organs in the Cav-1-/- mice (315). In summary, we demonstrate 
that dynamic interaction of the autophagic protein LC3B with Cav-1 and Fas regulate CS-
induced lung epithelial cell apoptosis. 
9.6.2 Beclin-1 promotes CS-induced apoptosis   
Beclin-1 is an integral autophagic protein, which functions in the initial formation of the 
phagophore (Figure 3). While Beclin-1-/- mice are embryonic lethal, suggesting a critical role for 
this protein in development, Beclin-1+/- mice are viable and have an increased propensity for 
tumor formation (316, 317). While basal protein expression is not appreciably decreased in the 
Beclin-1+/- mice, the mice demonstrate phenotypic variations when a stressor is applied (318). 
Consistent with these findings we also observed modest changes in protein expression and 
demonstrate that basal autophagosome formation and flux appear intact in the Beclin-1+/- mice, 
while CS exposed cells and mice lack stress-induced autophagy compared to wildtype controls 
(Figure 22C, 21 & 23B). 
Previous reports have described autophagy independent functions for Beclin-1. Beclin-1 
was originally identified as a BH3 domain-containing protein that interacts with the antiapoptotic 
Bcl-2 protein family, and more recently a c-terminal fragment of Beclin-1 generated by active 
caspases has been shown to localize to mitochondria to potentiate MOMP and cell death (270, 
279, 309). While the interaction of Bcl-2 with Beclin-1 has been shown to inhibit autophagy, the 
interaction thus far has been primarily one directional since overexpression of Beclin-1 has not 
been implicated in promoting apoptosis through the sequestration of Bcl-2 (271, 309). Previously 
we have demonstrated that CSE causes a time dependent reduction in Bcl-2 levels (8). In this 
study this effect was found to be completely reversed in Beclin-1+/- MTEC cultures. While in the 
Beclin-1+/+ cultures Bcl-2 decreased, in the Beclin-1+/- cultures Bcl-2 increased after 100 mg/m3 
CS TPM treatment (Figure 22C). Furthermore these results were confirmed in vivo (Figure 
23D). In addition to the Beclin-1+/- MTEC cultures expressing higher levels of antiapoptotic Bcl-
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2 upon smoke exposure, Beclin-1+/+ MTEC cultures treated with 100 mg/m3 produced more of 
the proapoptotic C-terminal cleavage fragment than the Beclin-1+/- cultures (Figure 22C). Since 
Beclin-1 has been implicated as a scaffold protein mediating many protein-protein interactions, 
this autophagy protein is likely to play a complex role in cell fate decisions. These data provide 
strong evidence for Beclin-1 promoting cell death via autophagy independent mechanisms.  
9.7 REGULATION OF AIRSPACE ENLARGEMENT BY AUTOPHAGIC 
PATHWAYS IN VIVO  
The murine model of CS exposure remains the preeminent model of COPD because the initiating 
insult is most relevant to the human disease (38, 42, 43). While the development of emphysema 
requires at least 3 mo of chronic CS exposure, depending on the mouse strain, acute exposures 
are frequently utilized for mechanistic studies (7). Since smoking pathology is extremely 
complex with many redundant injurious pathways involved, identifying critical mediators that 
demonstrate significant modulation of the disease process in vivo is a challenge.  
To assess the contribution of autophagic pathways implicated by the in vitro models in 
the regulation of cellular responses to CS in vivo, a number of murine CS exposures were carried 
out in this study using the following mouse strains: LC3B-/-, Beclin-1+/-, Cav-1-/-, and HDAC6-/Y. 
CS-induced airspace enlargement was significantly attenuated in the LC3B-/- and Beclin-1+/- 
mice, suggesting that these proteins are critical mediators of alveolar cell destruction (Figure 
15B & 23C). In contrast, Cav-1-/- mice were more susceptible to CS-induced airspace 
enlargement suggesting that this protein serves a protective function in epithelial cells following 
CS-induced cellular stress (Figure19D). These in vivo data implicate autophagy proteins in 
promoting CS-induced cell death and Cav-1-/- as a negative regulator of CS-induced injury.  
While autophagic flux was decreased in both the Beclin-1+/- and HDAC6-/Y mice, the 
HDAC6-/Y mice demonstrated a modest increase in susceptibility to airspace enlargement and 
induction of apoptotic indices (Figure 13). Although the airspace enlargement in the HDAC6-/Y 
mice was not statistically significant, the lack of a significant effect was not surprising given that 
there are a number of redundant proteins implicated in both selective autophagic degradation of 
ubiquitinated proteins and autophagosome-lysosome fusion (194, 319, 320). While cell death 
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was attenuated in the acute in vitro model, these in vivo data implicate HDAC6 in executing 
primarily protective functions following chronic exposure to CS. These data are consistent with 
the findings in literature that accumulation of misfolded proteins in the cytosol is detrimental to 
epithelial cell function and survival (280, 321, 322).  
HDAC6-/Y and Beclin-1-/+ mice and the respective wildtype control mice treated with CS 
for 6 mo weighed significantly less than the RA control mice, suggesting that these mutant mice 
have a metabolic response to CS that is not significantly different from wildtype mice  (Figure 
13B & 23A). Mice become rapidly hypophagic in response to CS and previous studies have 
demonstrated that CS exposure for 7 wk will cause a significant decrease in organ fat mass, and 
serum glucose, leptin, and insulin concentrations (323). These studies clearly demonstrate a 
connection between CS and metabolism, which is mediated through the central nervous system 
(324). Although the systemic metabolic effects of CS is beyond the scope of this thesis, this 
finding is highly relevant to this research, as starvation and calorie restriction are potent inducers 
of autophagy. 
These in vivo data support the mechanistic in vitro findings, and provide strong evidence 
for the autophagy proteins, LC3B and Beclin-1, exerting pro-pathogenic functions with respect 
to CS-induced emphysema development, by promoting apoptotic cell death. However, a 
cytoprotective function for autophagy, potentially through the mitigation of misfolded protein 
stress, is also suggested by these studies.  
9.8 CONCLUSIONS 
These data implicate autophagy and autophagic proteins in mediating lung epithelial cell fate 
following CS exposure. We have demonstrated that CS acutely induces autophagic activity in 
vitro and in vivo, and induces autophagic protein expression and autophagosome accumulation in 
these models. The data also indicate that the autophagic response to CS can be profoundly 
different depending on the dose and duration of exposure.  
Misfolded protein accumulation appeared to be a feature of COPD severity and CS 
exposure in vivo and in vitro. HDAC6 appeared to function in misfolded protein removal and 
play a role in cellular homeostasis. These observations support the speculation that HDAC6 
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mediated misfolded protein degradation by autophagy is an important homeostatic process that 
may contribute to cytoprotection in the context of CS-induced protein folding stress. 
Imaging analysis suggested that CS induces cilia shortening/loss and ciliated cell loss by 
two mechanisms: 1) ciliated cell shedding associated with loss of intercellular contacts and 2) 
reduced cilia numbers and length with maintained intercellular junction integrity. The data 
suggest that by mediating CS-induced cell death and direct degradation of cilia proteins, 
autophagy and autophagic proteins may contribute to the disruption of mucociliary clearance, 
which has been implicated in infection vulnerability thereby exacerbating COPD pathogenesis 
 Both LC3B and Beclin-1 were implicated in CS-induced cell death. While autophagy 
may play an active role in cell death by reducing the cells to bare essentials, these particular 
autophagy proteins appear to promote cell death by additional mechanisms. LC3B disrupted an 
antiapoptotic interaction between Fas and Cav-1, thereby regulating CS-induced extrinsic 
apoptosis, while Beclin-1 expression modulated the expression of antiapoptotic Bcl-2 and 
produced a proapoptotic cleavage fragment known to potentiate cell death in response to CS. 
From these studies a complex model of autophagy in COPD pathogenesis is emerging, in 
which autophagy proteins are initially upregulated to promote cytoprotection via misfolded 
protein removal, possibly leading to cilia shortening and loss as collateral damage, and mitigate 
CS-induced injury. Ultimately CS exposure may prime cells for cell death via many mechanism, 
which may not dependent on an active autophagic process. These data suggest that even if there 
were a decline in autophagic activity with late stage disease, the upregulation of these proteins 
would make the cells more vulnerable to cell death. 
In conclusion, CS-induced autophagy is not entirely “good” or “bad” and is dependent on 
dose and duration of exposure; therefore, targeting specific autophagy proteins particularly those 
with direct crosstalk to apoptosis may yield the greatest therapeutic benefits.   
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10.0  FUTURE DIRECTIONS 
While these studies have provided significant insights into the impact of CS on autophagic 
regulation and the subsequent functions of autophagy in the modulation of epithelial cell 
morphology and cell fate, there are many mechanistic pathways warranting further investigation. 
Further insights into the function of autophagy in cytoprotection in the lung, could be 
elucidated utilizing the HDAC6-/Y mice. To this end, the effects of HDAC6 on the accumulation 
of misfolded proteins and autophagic flux could be probed following CS treatment in vitro. 
Additional markers of cellular toxicity caused by misfolded protein accumulation could be 
determined by assaying LDH and epithelial cytokines in basal media from HDAC6-/Y MTEC 
cultures. Chemical modulators, which diminish and enhance misfolded proteins are abundant, 
and could be used to determine the effects on cell viability in HDAC6-/Y MTEC cultures. In the 
long-term, mice with a protein conformational disease of the lung could be assessed for CS-
induced emphysema with autophagy modulating drug intervention.   
Many studies on CS-induced cilia changes are impeded by the use of in vivo models; 
therefore, the MTEC cultures are a unique opportunity to finally address an underlying 
mechanism. While desquamation was a significant contributing factor to CS-induced ciliated cell 
loss, further morphometric analysis of SEM images to quantitatively evaluate the effects of CS 
on cilia loss and shortening at the subtoxic dose of 50 mg/m3 would provide a better 
understanding of the more subtle effects of CS on cilia. Once a morphometric rubric is 
established, the functional role of HDAC6 and Beclin-1 on CS induced cilia loss could then be 
evaluated. Furthermore, there is a possibility that cilia proteins comprise a proportion of the 
misfolded protein aggregates; therefore, autophagic proteins may not be directly involved in the 
regulation of cilia loss and agents that promote protein folding may be better targets of 
intervention. Exogenous addition of chemical chaperones has been shown to promote protein 
folding in contexts of cell stress (325). 
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While hypophagia observed in mice is consistent with human smoker behavior, calorie 
restriction is a confounding factor for measuring the direct impact of CS on autophagic activity 
in these mice. Either removing or blocking the appetite suppressing nicotinic compounds from 
the CS would allow for a clearer assessment of CS-induced autophagy. This finding in particular 
suggests that a greater understanding of metabolism in smokers and smokers that develop COPD 
is necessary. 
These studies provide substantial evidence demonstrating that Beclin-1 and LC3B 
promote CS-induced cell death. Previously published literature and our own findings indicate 
that the molecular mechanisms by which these proteins promote apoptosis may not depend on 
autophagy. However, we have consistently found that cells exposed to CS die with an 
accumulation of autophagosomes, whether flux is increased or not, may not be as essential as the 
role of encapsulation and packaging of cytoplasmic material for phagocytosis. Recent work has 
demonstrated that phagocytosis of autophagosome filled 3T3 cells promotes inflammasome 
activation (326). Future work on the functional significance of epithelial cells succumbing to cell 
death filled with autophagic vacuoles may yield important insights into disease pathology. 
There is widespread skepticism at this time with regard to autophagic cell death, but the 
CS model is one in which knockdown and overexpression with multiple autophagy proteins 
consistently demonstrates a contribution of autophagy in mediating apoptotic cell death. While 
inhibition of both autophagy and apoptosis promote cell survival following CS treatment, the 
contribution of both pathways should be more decisively determined in order to elucidate the 
potential synergy between these pathways and identify molecular mechanisms that regulate the 
switch from cytoprotection to cell death. 
  Furthermore, our studies using LC3B-/- and Beclin-1+/- are not completely autophagy 
deficient. The requirement for autophagy in CS-induced cell death, would be greatly bolstered by 
using a model in which autophagy is inhibited completely. Recently lung specific inducible 
deletion of Atg7 was described; however, there was a gross disruption of airway morphology 
(310). A more viable method for inhibiting autophagy may require the acquisition of the Tat-
Atg5 (K130R) construct, which is a membrane-crossing dominant negative protein that 
suppresses the autophagic process (327). Use of this construct would be logistically feasible in 
the MTEC cultures, and assessing the effects of complete autophagy deficiency would make the 
contribution of autophagic flux in CS-induced cell death more convincing.  
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Autophagy deficiency has recently been linked to enhanced antioxidant protein 
expression, via p62-mediated sequestration of Keap1 and subsequent nuclear localization of Nrf-
2 (189, 190, 224). Recently the specific deletion of Atg7 in the airways was shown to similarly 
induced transcription of antioxidant proteins (310). Since oxidant-antioxidant imbalance is a 
major contributing factor to COPD, enhanced Nrf-2 transcriptional activity may be enough to 
provide the survival advantage observed in the autophagy deficient mice.  
The field of autophagy is exciting and perplexing. The contribution of this process in 
lung disease is only beginning to be elucidated and based on the modulation of autophagy by CS 
there is great potential for identification of therapeutic targets.  
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